Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ZNF711_TFAP2A_TFAP2D
Z-value: 1.32
Motif logo
Transcription factors associated with ZNF711_TFAP2A_TFAP2D
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF711
|
ENSG00000147180.12 | zinc finger protein 711 |
|
TFAP2A
|
ENSG00000137203.6 | transcription factor AP-2 alpha |
|
TFAP2D
|
ENSG00000008197.4 | transcription factor AP-2 delta |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF711 | hg19_v2_chrX_+_84499081_84499115, hg19_v2_chrX_+_84498989_84499003, hg19_v2_chrX_+_84499038_84499078 | -0.50 | 2.0e-15 | Click! |
| TFAP2A | hg19_v2_chr6_-_10415470_10415508 | 0.28 | 2.0e-05 | Click! |
Activity profile of ZNF711_TFAP2A_TFAP2D motif
Sorted Z-values of ZNF711_TFAP2A_TFAP2D motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_185542761 | 212.17 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr3_-_185542817 | 203.18 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr2_-_10588630 | 143.62 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
| chr22_+_21921994 | 143.28 |
ENST00000545681.1
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3 |
| chr20_-_60718430 | 134.03 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
| chr11_-_14380664 | 125.61 |
ENST00000545643.1
ENST00000256196.4 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
| chrX_-_153285395 | 125.34 |
ENST00000369980.3
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
| chrX_-_153285251 | 121.17 |
ENST00000444230.1
ENST00000393682.1 ENST00000393687.2 ENST00000429936.2 ENST00000369974.2 |
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
| chr16_+_29817841 | 116.94 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr5_+_72112470 | 115.75 |
ENST00000447967.2
ENST00000523768.1 |
TNPO1
|
transportin 1 |
| chr19_-_55919087 | 113.41 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
| chr11_-_2950642 | 112.95 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
| chr4_-_71705060 | 112.10 |
ENST00000514161.1
|
GRSF1
|
G-rich RNA sequence binding factor 1 |
| chr4_-_71705027 | 111.01 |
ENST00000545193.1
|
GRSF1
|
G-rich RNA sequence binding factor 1 |
| chr1_+_155178481 | 108.20 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
| chr17_-_79481666 | 103.43 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
| chr5_-_133340326 | 102.87 |
ENST00000425992.1
ENST00000395044.3 ENST00000395047.2 |
VDAC1
|
voltage-dependent anion channel 1 |
| chr11_-_46142948 | 102.08 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr22_+_43547937 | 101.52 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
| chr3_+_171758344 | 101.05 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
| chr14_+_56046990 | 100.35 |
ENST00000438792.2
ENST00000395314.3 ENST00000395308.1 |
KTN1
|
kinectin 1 (kinesin receptor) |
| chr12_-_109125285 | 96.91 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
| chr17_-_73178599 | 94.98 |
ENST00000578238.1
|
SUMO2
|
small ubiquitin-like modifier 2 |
| chr16_-_85833160 | 94.54 |
ENST00000435200.2
|
EMC8
|
ER membrane protein complex subunit 8 |
| chr3_+_184079492 | 91.88 |
ENST00000456318.1
ENST00000412877.1 ENST00000438240.1 |
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
| chr4_+_110354928 | 91.53 |
ENST00000504968.2
ENST00000399100.2 ENST00000265175.5 |
SEC24B
|
SEC24 family member B |
| chr21_-_18985230 | 90.72 |
ENST00000457956.1
ENST00000348354.6 |
BTG3
|
BTG family, member 3 |
| chr2_+_10262442 | 90.70 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
| chr17_-_62658186 | 89.98 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
| chr9_+_131451480 | 89.33 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
| chr2_+_235860616 | 88.96 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
| chr1_-_212004090 | 88.41 |
ENST00000366997.4
|
LPGAT1
|
lysophosphatidylglycerol acyltransferase 1 |
| chr3_+_155588375 | 87.96 |
ENST00000295920.7
|
GMPS
|
guanine monphosphate synthase |
| chr12_+_104609550 | 87.58 |
ENST00000525566.1
ENST00000429002.2 |
TXNRD1
|
thioredoxin reductase 1 |
| chr12_-_112856623 | 86.99 |
ENST00000551291.2
|
RPL6
|
ribosomal protein L6 |
| chr2_-_174828892 | 86.71 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr12_-_76478446 | 86.49 |
ENST00000393263.3
ENST00000548044.1 ENST00000547704.1 ENST00000431879.3 ENST00000549596.1 ENST00000550934.1 ENST00000551600.1 ENST00000547479.1 ENST00000547773.1 ENST00000544816.1 ENST00000542344.1 ENST00000548273.1 |
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr21_-_18985158 | 85.95 |
ENST00000339775.6
|
BTG3
|
BTG family, member 3 |
| chr4_-_103789996 | 85.80 |
ENST00000508238.1
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
| chr16_-_85833109 | 85.64 |
ENST00000253457.3
|
EMC8
|
ER membrane protein complex subunit 8 |
| chr2_+_181845298 | 85.19 |
ENST00000410062.4
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr3_-_53290016 | 83.96 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
| chr11_+_842808 | 83.70 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
| chr9_+_91926103 | 83.54 |
ENST00000314355.6
|
CKS2
|
CDC28 protein kinase regulatory subunit 2 |
| chr19_-_14628645 | 83.18 |
ENST00000598235.1
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr9_-_113018746 | 82.92 |
ENST00000374515.5
|
TXN
|
thioredoxin |
| chr17_-_73149921 | 82.22 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
| chr2_-_10587897 | 81.64 |
ENST00000405333.1
ENST00000443218.1 |
ODC1
|
ornithine decarboxylase 1 |
| chr1_-_94374946 | 81.60 |
ENST00000370238.3
|
GCLM
|
glutamate-cysteine ligase, modifier subunit |
| chr1_-_150947343 | 81.59 |
ENST00000271688.6
ENST00000368954.5 |
CERS2
|
ceramide synthase 2 |
| chr1_+_41445413 | 81.30 |
ENST00000541520.1
|
CTPS1
|
CTP synthase 1 |
| chr12_-_76477707 | 81.10 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr4_+_174089904 | 81.08 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
| chr1_+_43148625 | 80.90 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr13_-_31039375 | 80.65 |
ENST00000399494.1
|
HMGB1
|
high mobility group box 1 |
| chr1_+_155178518 | 80.59 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
| chr15_+_80351977 | 80.53 |
ENST00000559157.1
ENST00000561012.1 ENST00000564367.1 ENST00000558494.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
| chrX_+_49028265 | 80.40 |
ENST00000376322.3
ENST00000376327.5 |
PLP2
|
proteolipid protein 2 (colonic epithelium-enriched) |
| chr18_+_3449821 | 80.14 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr17_+_1944790 | 79.99 |
ENST00000575162.1
|
DPH1
|
diphthamide biosynthesis 1 |
| chr16_-_87903079 | 79.86 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr12_-_76478417 | 79.66 |
ENST00000552342.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr16_-_29466285 | 78.47 |
ENST00000330978.3
|
BOLA2
|
bolA family member 2 |
| chr2_+_216176761 | 78.01 |
ENST00000540518.1
ENST00000435675.1 |
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
| chr19_+_33865218 | 77.99 |
ENST00000585933.2
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma |
| chr16_-_88851618 | 77.50 |
ENST00000301015.9
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1 |
| chr7_+_26241325 | 77.18 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
| chr10_-_13390021 | 76.99 |
ENST00000537130.1
|
SEPHS1
|
selenophosphate synthetase 1 |
| chr15_+_63796779 | 76.63 |
ENST00000561442.1
ENST00000560070.1 ENST00000540797.1 ENST00000380324.3 ENST00000268049.7 ENST00000536001.1 ENST00000539772.1 |
USP3
|
ubiquitin specific peptidase 3 |
| chr1_-_40042416 | 76.47 |
ENST00000372857.3
ENST00000372856.3 ENST00000531243.2 ENST00000451091.2 |
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr8_+_91013676 | 76.45 |
ENST00000519410.1
ENST00000522161.1 ENST00000517761.1 ENST00000520227.1 |
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial |
| chr12_-_76478386 | 76.41 |
ENST00000535020.2
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr1_+_87170577 | 76.22 |
ENST00000482504.1
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1 |
| chr1_+_236558694 | 76.18 |
ENST00000359362.5
|
EDARADD
|
EDAR-associated death domain |
| chr9_+_131452239 | 75.61 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
| chr3_-_182698381 | 75.25 |
ENST00000292782.4
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1 |
| chr10_-_17659234 | 75.03 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
| chr3_+_33155525 | 74.46 |
ENST00000449224.1
|
CRTAP
|
cartilage associated protein |
| chr15_+_80351910 | 74.41 |
ENST00000261749.6
ENST00000561060.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
| chr16_+_2521500 | 74.33 |
ENST00000293973.1
|
NTN3
|
netrin 3 |
| chr11_-_64014379 | 73.91 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr17_-_4269768 | 73.88 |
ENST00000396981.2
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1 |
| chr4_-_1713977 | 73.24 |
ENST00000318386.4
|
SLBP
|
stem-loop binding protein |
| chr1_-_8939265 | 73.11 |
ENST00000489867.1
|
ENO1
|
enolase 1, (alpha) |
| chr19_-_1568057 | 72.78 |
ENST00000402693.4
ENST00000388824.6 |
MEX3D
|
mex-3 RNA binding family member D |
| chr8_+_26149007 | 72.45 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
| chr14_+_58711539 | 72.31 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
| chr9_-_113018835 | 72.06 |
ENST00000374517.5
|
TXN
|
thioredoxin |
| chr14_+_105886150 | 72.03 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
| chr5_+_170814803 | 72.00 |
ENST00000521672.1
ENST00000351986.6 ENST00000393820.2 ENST00000523622.1 |
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| chr4_-_100871506 | 71.84 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
| chr2_+_216176540 | 71.49 |
ENST00000236959.9
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
| chr14_+_54863667 | 71.35 |
ENST00000335183.6
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
| chr11_-_64013663 | 71.33 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr7_+_16685756 | 71.30 |
ENST00000415365.1
ENST00000258761.3 ENST00000433922.2 ENST00000452975.2 ENST00000405202.1 |
BZW2
|
basic leucine zipper and W2 domains 2 |
| chr17_+_45608430 | 71.29 |
ENST00000322157.4
|
NPEPPS
|
aminopeptidase puromycin sensitive |
| chr9_+_138392483 | 71.18 |
ENST00000241600.5
|
MRPS2
|
mitochondrial ribosomal protein S2 |
| chr20_+_35202909 | 70.84 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
| chr2_-_106015491 | 70.75 |
ENST00000408995.1
ENST00000393353.3 ENST00000322142.8 |
FHL2
|
four and a half LIM domains 2 |
| chr13_+_28195988 | 70.56 |
ENST00000399697.3
ENST00000399696.1 |
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
| chr17_-_73150599 | 70.41 |
ENST00000392566.2
ENST00000581874.1 |
HN1
|
hematological and neurological expressed 1 |
| chrX_-_153599578 | 70.34 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr1_+_11072696 | 70.32 |
ENST00000240185.3
ENST00000476201.1 |
TARDBP
|
TAR DNA binding protein |
| chr22_-_39096661 | 70.32 |
ENST00000216039.5
|
JOSD1
|
Josephin domain containing 1 |
| chr1_+_228270361 | 70.24 |
ENST00000272102.5
ENST00000540651.1 |
ARF1
|
ADP-ribosylation factor 1 |
| chr1_-_156721502 | 70.16 |
ENST00000357325.5
|
HDGF
|
hepatoma-derived growth factor |
| chrX_+_23682379 | 70.15 |
ENST00000379349.1
|
PRDX4
|
peroxiredoxin 4 |
| chr4_-_1714037 | 70.09 |
ENST00000488267.1
ENST00000429429.2 ENST00000480936.1 |
SLBP
|
stem-loop binding protein |
| chr5_-_133340682 | 70.09 |
ENST00000265333.3
|
VDAC1
|
voltage-dependent anion channel 1 |
| chrX_-_153718953 | 70.09 |
ENST00000369649.4
ENST00000393586.1 |
SLC10A3
|
solute carrier family 10, member 3 |
| chrX_+_64887512 | 70.05 |
ENST00000360270.5
|
MSN
|
moesin |
| chr4_+_1723197 | 69.76 |
ENST00000485989.2
ENST00000313288.4 |
TACC3
|
transforming, acidic coiled-coil containing protein 3 |
| chr16_-_66864806 | 69.33 |
ENST00000566336.1
ENST00000394074.2 ENST00000563185.2 ENST00000359087.4 ENST00000379463.2 ENST00000565535.1 ENST00000290810.3 |
NAE1
|
NEDD8 activating enzyme E1 subunit 1 |
| chr19_-_1095330 | 69.14 |
ENST00000586746.1
|
POLR2E
|
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa |
| chr1_+_155179012 | 69.09 |
ENST00000609421.1
|
MTX1
|
metaxin 1 |
| chr3_-_12705600 | 69.06 |
ENST00000542177.1
ENST00000442415.2 ENST00000251849.4 |
RAF1
|
v-raf-1 murine leukemia viral oncogene homolog 1 |
| chrX_+_118602363 | 68.79 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
| chr5_+_172410757 | 68.75 |
ENST00000519374.1
ENST00000519911.1 ENST00000265093.4 ENST00000517669.1 |
ATP6V0E1
|
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
| chr6_+_34204642 | 68.58 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr14_+_56046914 | 68.54 |
ENST00000413890.2
ENST00000395309.3 ENST00000554567.1 ENST00000555498.1 |
KTN1
|
kinectin 1 (kinesin receptor) |
| chr3_-_64009102 | 68.51 |
ENST00000478185.1
ENST00000482510.1 ENST00000497323.1 ENST00000492933.1 ENST00000295901.4 |
PSMD6
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
| chr1_-_24126892 | 68.28 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
| chr11_+_70049269 | 68.06 |
ENST00000301838.4
|
FADD
|
Fas (TNFRSF6)-associated via death domain |
| chr10_-_33246722 | 68.01 |
ENST00000437302.1
ENST00000396033.2 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
| chr8_-_27695552 | 67.97 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
| chr17_-_46178527 | 67.93 |
ENST00000393408.3
|
CBX1
|
chromobox homolog 1 |
| chr2_+_181845074 | 67.46 |
ENST00000602959.1
ENST00000602479.1 ENST00000392415.2 ENST00000602291.1 |
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr9_+_128509663 | 67.44 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr2_+_113403434 | 67.22 |
ENST00000272542.3
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1 |
| chrX_-_152989798 | 66.98 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
| chr22_+_24951436 | 66.73 |
ENST00000215829.3
|
SNRPD3
|
small nuclear ribonucleoprotein D3 polypeptide 18kDa |
| chr7_+_98972345 | 66.68 |
ENST00000418347.2
ENST00000429246.1 ENST00000417330.1 ENST00000431816.1 ENST00000427217.1 ENST00000458033.1 ENST00000451682.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr15_-_63450192 | 66.47 |
ENST00000411926.1
|
RPS27L
|
ribosomal protein S27-like |
| chr1_+_10459111 | 66.30 |
ENST00000541529.1
ENST00000270776.8 ENST00000483936.1 ENST00000538557.1 |
PGD
|
phosphogluconate dehydrogenase |
| chr16_-_85722530 | 66.27 |
ENST00000253462.3
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog) |
| chr9_+_100745615 | 66.17 |
ENST00000339399.4
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
| chr11_-_65325430 | 66.06 |
ENST00000322147.4
|
LTBP3
|
latent transforming growth factor beta binding protein 3 |
| chr8_-_102217796 | 65.84 |
ENST00000519744.1
ENST00000311212.4 ENST00000521272.1 ENST00000519882.1 |
ZNF706
|
zinc finger protein 706 |
| chr17_+_1733276 | 65.80 |
ENST00000254719.5
|
RPA1
|
replication protein A1, 70kDa |
| chr2_-_44223138 | 65.69 |
ENST00000260665.7
|
LRPPRC
|
leucine-rich pentatricopeptide repeat containing |
| chr11_+_842928 | 65.57 |
ENST00000397408.1
|
TSPAN4
|
tetraspanin 4 |
| chr11_+_1968508 | 65.39 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
| chr10_+_131934643 | 65.33 |
ENST00000331244.5
ENST00000368644.1 |
GLRX3
|
glutaredoxin 3 |
| chr4_-_103790026 | 64.95 |
ENST00000338145.3
ENST00000357194.6 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
| chr3_+_23847394 | 64.94 |
ENST00000306627.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
| chr11_-_46142615 | 64.91 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr15_+_41624892 | 64.83 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
| chrX_-_153718988 | 64.72 |
ENST00000263512.4
ENST00000393587.4 ENST00000453912.1 |
SLC10A3
|
solute carrier family 10, member 3 |
| chr9_+_128509624 | 64.49 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr1_+_162531294 | 64.48 |
ENST00000367926.4
ENST00000271469.3 |
UAP1
|
UDP-N-acteylglucosamine pyrophosphorylase 1 |
| chr2_+_48010312 | 64.36 |
ENST00000540021.1
|
MSH6
|
mutS homolog 6 |
| chrX_-_154688276 | 64.35 |
ENST00000369445.2
|
F8A3
|
coagulation factor VIII-associated 3 |
| chr15_+_65823092 | 63.97 |
ENST00000566074.1
|
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
| chr7_+_66386204 | 63.91 |
ENST00000341567.4
ENST00000607045.1 |
TMEM248
|
transmembrane protein 248 |
| chr19_+_47634039 | 63.83 |
ENST00000597808.1
ENST00000413379.3 ENST00000600706.1 ENST00000540850.1 ENST00000598840.1 ENST00000600753.1 ENST00000270225.7 ENST00000392776.3 |
SAE1
|
SUMO1 activating enzyme subunit 1 |
| chr22_+_20105259 | 63.78 |
ENST00000416427.1
ENST00000421656.1 ENST00000423859.1 ENST00000418705.2 |
RANBP1
|
RAN binding protein 1 |
| chr7_+_12726474 | 63.77 |
ENST00000396662.1
ENST00000356797.3 ENST00000396664.2 |
ARL4A
|
ADP-ribosylation factor-like 4A |
| chr19_+_14672755 | 63.61 |
ENST00000594545.1
|
TECR
|
trans-2,3-enoyl-CoA reductase |
| chr2_+_85198216 | 63.10 |
ENST00000456682.1
ENST00000409785.4 |
KCMF1
|
potassium channel modulatory factor 1 |
| chr3_+_23847432 | 62.98 |
ENST00000346855.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
| chr22_-_47134077 | 62.98 |
ENST00000541677.1
ENST00000216264.8 |
CERK
|
ceramide kinase |
| chr9_+_138391805 | 62.93 |
ENST00000371785.1
|
MRPS2
|
mitochondrial ribosomal protein S2 |
| chr1_-_3816779 | 62.79 |
ENST00000361605.3
|
C1orf174
|
chromosome 1 open reading frame 174 |
| chr18_+_3449695 | 62.57 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr11_-_535515 | 62.41 |
ENST00000311189.7
ENST00000451590.1 ENST00000417302.1 |
HRAS
|
Harvey rat sarcoma viral oncogene homolog |
| chr8_+_145582231 | 62.34 |
ENST00000526338.1
ENST00000402965.1 ENST00000534725.1 ENST00000532887.1 ENST00000329994.2 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
| chr11_-_34937858 | 62.30 |
ENST00000278359.5
|
APIP
|
APAF1 interacting protein |
| chr8_+_145582217 | 62.18 |
ENST00000530047.1
ENST00000527078.1 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
| chr1_+_2160134 | 62.10 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
| chr1_+_182992545 | 61.82 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
| chr18_+_158513 | 61.76 |
ENST00000400266.3
ENST00000580410.1 ENST00000383589.2 ENST00000261601.7 |
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) |
| chr1_+_228270784 | 61.68 |
ENST00000541182.1
|
ARF1
|
ADP-ribosylation factor 1 |
| chr16_+_67063142 | 61.65 |
ENST00000412916.2
|
CBFB
|
core-binding factor, beta subunit |
| chr5_-_68665084 | 61.49 |
ENST00000509462.1
|
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
| chr11_-_64013288 | 61.45 |
ENST00000542235.1
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr8_-_101963482 | 61.43 |
ENST00000419477.2
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
| chr19_+_17413663 | 61.39 |
ENST00000594999.1
|
MRPL34
|
mitochondrial ribosomal protein L34 |
| chr2_-_106015527 | 61.29 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
| chr8_-_144679532 | 61.20 |
ENST00000534380.1
ENST00000533494.1 ENST00000531218.1 ENST00000526340.1 ENST00000533204.1 ENST00000532400.1 ENST00000529516.1 ENST00000534377.1 ENST00000531621.1 ENST00000530191.1 ENST00000524900.1 ENST00000526838.1 ENST00000531931.1 ENST00000534475.1 ENST00000442189.2 ENST00000524624.1 ENST00000532596.1 ENST00000529832.1 ENST00000530306.1 ENST00000530545.1 ENST00000525261.1 ENST00000534804.1 ENST00000528303.1 ENST00000528610.1 |
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
| chr22_+_20105012 | 61.17 |
ENST00000331821.3
ENST00000411892.1 |
RANBP1
|
RAN binding protein 1 |
| chr18_+_657733 | 61.16 |
ENST00000323250.5
ENST00000323224.7 |
TYMS
|
thymidylate synthetase |
| chr20_+_3776936 | 61.04 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
| chr12_+_96252706 | 60.98 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
| chrX_-_152989531 | 60.96 |
ENST00000458587.2
ENST00000416815.1 |
BCAP31
|
B-cell receptor-associated protein 31 |
| chr6_-_18265050 | 60.92 |
ENST00000397239.3
|
DEK
|
DEK oncogene |
| chr7_-_99698338 | 60.89 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
| chr12_+_69004619 | 60.68 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
| chr17_+_80186908 | 60.65 |
ENST00000582743.1
ENST00000578684.1 ENST00000577650.1 ENST00000582715.1 |
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
| chr3_+_184080387 | 60.61 |
ENST00000455712.1
|
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
| chr14_-_102553371 | 60.39 |
ENST00000553585.1
ENST00000216281.8 |
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
| chr14_+_54863739 | 60.35 |
ENST00000541304.1
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
| chr18_+_657578 | 60.27 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
| chr15_-_49447771 | 60.08 |
ENST00000558843.1
ENST00000542928.1 ENST00000561248.1 |
COPS2
|
COP9 signalosome subunit 2 |
| chr10_+_81107271 | 59.82 |
ENST00000448165.1
|
PPIF
|
peptidylprolyl isomerase F |
| chr6_-_4135825 | 59.79 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr18_+_11981427 | 59.75 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr7_+_26241310 | 59.68 |
ENST00000396386.2
|
CBX3
|
chromobox homolog 3 |
| chr6_+_155054459 | 59.62 |
ENST00000367178.3
ENST00000417268.1 ENST00000367186.4 |
SCAF8
|
SR-related CTD-associated factor 8 |
| chr14_-_105487381 | 59.51 |
ENST00000392590.3
ENST00000336219.3 |
CDCA4
|
cell division cycle associated 4 |
| chr7_-_5569588 | 59.51 |
ENST00000417101.1
|
ACTB
|
actin, beta |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF711_TFAP2A_TFAP2D
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 72.8 | 291.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 60.7 | 242.9 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 47.6 | 190.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 46.3 | 138.8 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
| 43.5 | 174.1 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 43.5 | 174.0 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 43.4 | 130.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 43.3 | 129.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 43.2 | 129.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 42.5 | 127.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 39.8 | 119.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 39.6 | 158.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 39.5 | 118.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 38.4 | 115.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 38.2 | 114.6 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 37.2 | 111.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 36.6 | 109.8 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 36.5 | 109.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 36.1 | 216.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 35.8 | 107.3 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 35.7 | 142.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 35.5 | 177.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 35.0 | 140.1 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 34.6 | 69.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 34.4 | 103.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 34.2 | 136.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 34.1 | 272.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 33.8 | 135.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 33.8 | 101.2 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 33.0 | 329.5 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 32.9 | 32.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 32.5 | 130.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 31.9 | 159.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 31.9 | 95.8 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 31.7 | 126.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 31.6 | 94.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 31.5 | 157.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 31.4 | 31.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 31.3 | 125.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 31.2 | 93.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 30.5 | 152.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 30.5 | 91.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 30.5 | 121.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 30.3 | 121.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 29.4 | 146.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 29.3 | 29.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 29.3 | 117.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 29.2 | 204.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 29.2 | 116.6 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 29.1 | 291.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 29.1 | 87.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 28.7 | 57.4 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 28.6 | 114.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 28.4 | 170.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 28.2 | 112.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 28.1 | 84.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 27.5 | 82.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 27.1 | 162.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 27.1 | 81.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 26.9 | 80.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 26.7 | 26.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 26.7 | 160.1 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 26.4 | 52.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 26.3 | 26.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 26.3 | 157.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 26.3 | 183.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 26.2 | 261.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 26.1 | 417.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 25.8 | 103.2 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 25.8 | 154.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 25.8 | 77.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 25.4 | 253.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 25.4 | 380.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 25.4 | 253.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 25.3 | 76.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 25.3 | 404.7 | GO:0043248 | proteasome assembly(GO:0043248) |
| 25.3 | 75.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 24.8 | 74.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 24.6 | 49.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 24.5 | 73.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 24.4 | 122.2 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 24.4 | 73.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 24.3 | 170.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 24.3 | 73.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 24.3 | 121.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 24.1 | 192.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 24.0 | 24.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 23.7 | 237.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 23.7 | 94.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 23.5 | 211.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 23.4 | 70.2 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 23.3 | 69.9 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 23.3 | 116.4 | GO:0015862 | uridine transport(GO:0015862) |
| 23.2 | 46.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 23.1 | 23.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 23.1 | 46.3 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 22.7 | 113.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 22.6 | 135.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 22.6 | 994.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 22.5 | 67.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 22.5 | 90.0 | GO:0015853 | adenine transport(GO:0015853) |
| 22.3 | 67.0 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 22.3 | 22.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 22.2 | 22.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 22.1 | 287.4 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 22.1 | 44.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 21.9 | 21.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 21.9 | 65.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 21.8 | 152.9 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
| 21.8 | 65.5 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 21.8 | 65.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 21.8 | 1892.4 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 21.7 | 65.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 21.6 | 107.9 | GO:0035900 | response to isolation stress(GO:0035900) |
| 21.6 | 129.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 21.6 | 409.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 21.3 | 85.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 21.3 | 85.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 21.2 | 169.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 21.2 | 63.5 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 21.1 | 105.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 21.1 | 168.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 21.0 | 146.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 21.0 | 83.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 20.9 | 62.8 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 20.8 | 208.5 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 20.8 | 103.9 | GO:1904044 | response to aldosterone(GO:1904044) |
| 20.5 | 82.0 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
| 20.5 | 81.9 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 20.5 | 634.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 20.4 | 61.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 20.4 | 306.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 20.4 | 81.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 20.3 | 162.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 20.1 | 140.6 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 20.0 | 80.1 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 19.9 | 19.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 19.9 | 99.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 19.9 | 139.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 19.9 | 39.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 19.9 | 19.9 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 19.8 | 39.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 19.7 | 98.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 19.7 | 432.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 19.6 | 98.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 19.5 | 1441.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 19.5 | 97.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 19.4 | 19.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 19.3 | 115.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 19.3 | 115.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 19.3 | 77.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 19.3 | 96.3 | GO:0043144 | snoRNA processing(GO:0043144) |
| 19.2 | 57.7 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 19.2 | 95.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 19.2 | 76.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 19.1 | 76.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 19.1 | 76.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 19.0 | 76.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 19.0 | 57.0 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 18.9 | 56.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 18.9 | 207.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 18.8 | 150.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 18.8 | 150.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 18.8 | 93.8 | GO:0030047 | actin modification(GO:0030047) |
| 18.6 | 223.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 18.6 | 74.3 | GO:0051664 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 18.5 | 111.0 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 18.5 | 55.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 18.4 | 18.4 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 18.4 | 588.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 18.4 | 73.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 18.4 | 91.9 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 18.4 | 18.4 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 18.3 | 55.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 18.3 | 73.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 18.3 | 54.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 18.2 | 54.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 18.2 | 91.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 18.2 | 54.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 18.1 | 72.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 18.0 | 54.0 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 18.0 | 71.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 17.8 | 107.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 17.8 | 53.5 | GO:1905068 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 17.8 | 35.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 17.8 | 106.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 17.7 | 106.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 17.7 | 53.1 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 17.7 | 53.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 17.6 | 35.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 17.6 | 17.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 17.6 | 87.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 17.4 | 34.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 17.4 | 34.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 17.4 | 86.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 17.3 | 173.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 17.2 | 171.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 17.0 | 34.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 17.0 | 67.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 16.9 | 152.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 16.9 | 16.9 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 16.7 | 184.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 16.7 | 50.1 | GO:1904744 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
| 16.7 | 33.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) nucleotide transmembrane transport(GO:1901679) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 16.6 | 165.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 16.6 | 66.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 16.5 | 33.0 | GO:0046075 | dTTP metabolic process(GO:0046075) |
| 16.5 | 33.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 16.5 | 49.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 16.4 | 49.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 16.4 | 16.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 16.3 | 32.5 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 16.3 | 113.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 16.2 | 64.8 | GO:0072683 | T cell extravasation(GO:0072683) |
| 16.1 | 144.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 16.0 | 16.0 | GO:0048254 | snoRNA localization(GO:0048254) |
| 16.0 | 64.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 15.9 | 127.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 15.8 | 15.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 15.7 | 63.0 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 15.7 | 94.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 15.7 | 47.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 15.7 | 62.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 15.6 | 46.9 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 15.6 | 93.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 15.5 | 15.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 15.5 | 62.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 15.4 | 30.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 15.4 | 61.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 15.4 | 92.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 15.4 | 61.5 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 15.4 | 138.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 15.3 | 30.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 15.3 | 184.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 15.3 | 413.6 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 15.2 | 15.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 15.2 | 30.3 | GO:0044211 | CTP salvage(GO:0044211) |
| 15.2 | 136.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 15.2 | 90.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 15.1 | 60.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 15.1 | 45.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 15.1 | 120.6 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 15.0 | 15.0 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 15.0 | 44.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 14.9 | 119.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 14.9 | 74.7 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 14.9 | 118.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 14.8 | 89.1 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 14.8 | 14.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 14.7 | 14.7 | GO:0034214 | protein hexamerization(GO:0034214) |
| 14.7 | 176.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 14.7 | 14.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 14.7 | 14.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 14.7 | 102.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 14.6 | 14.6 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 14.6 | 29.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 14.5 | 58.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 14.5 | 101.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
| 14.4 | 28.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 14.2 | 42.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 14.2 | 14.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 14.1 | 84.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 14.0 | 41.9 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 14.0 | 41.9 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 13.9 | 27.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 13.8 | 41.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 13.8 | 165.5 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 13.8 | 68.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 13.8 | 68.8 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 13.7 | 123.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 13.7 | 329.6 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 13.7 | 288.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 13.7 | 54.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 13.5 | 40.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 13.5 | 634.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 13.4 | 53.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 13.4 | 53.5 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 13.4 | 40.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 13.3 | 40.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 13.3 | 146.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 13.3 | 13.3 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 13.3 | 13.3 | GO:0007031 | peroxisome organization(GO:0007031) |
| 13.3 | 186.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 13.2 | 145.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 13.2 | 92.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 13.2 | 52.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 13.2 | 13.2 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 13.1 | 39.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 13.1 | 157.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 13.1 | 26.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 13.1 | 52.3 | GO:0015866 | ADP transport(GO:0015866) |
| 13.0 | 64.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 12.9 | 38.8 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 12.9 | 12.9 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
| 12.9 | 38.6 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 12.9 | 51.4 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 12.8 | 25.7 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 12.8 | 115.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 12.8 | 38.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 12.8 | 63.8 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 12.8 | 25.5 | GO:0046782 | regulation of viral transcription(GO:0046782) |
| 12.7 | 38.2 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 12.7 | 38.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 12.7 | 393.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 12.7 | 38.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 12.7 | 63.4 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 12.7 | 76.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 12.7 | 633.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 12.7 | 12.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 12.6 | 50.6 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 12.6 | 25.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 12.6 | 37.7 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 12.6 | 12.6 | GO:0060613 | fat pad development(GO:0060613) |
| 12.5 | 62.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 12.4 | 24.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 12.4 | 24.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 12.3 | 49.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 12.3 | 36.9 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 12.3 | 110.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 12.3 | 110.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 12.3 | 12.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 12.2 | 48.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 12.1 | 36.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 12.1 | 24.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 12.1 | 12.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 12.1 | 36.3 | GO:0048382 | mesendoderm development(GO:0048382) |
| 12.0 | 120.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 12.0 | 60.2 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 12.0 | 23.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 11.9 | 23.8 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 11.9 | 95.3 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 11.9 | 11.9 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 11.9 | 225.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 11.9 | 83.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 11.9 | 11.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 11.9 | 35.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 11.9 | 59.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 11.9 | 83.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 11.8 | 35.4 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 11.8 | 94.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 11.8 | 94.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 11.8 | 23.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 11.8 | 35.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 11.7 | 35.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 11.7 | 492.5 | GO:0032392 | DNA geometric change(GO:0032392) |
| 11.7 | 1453.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 11.6 | 337.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 11.6 | 46.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 11.6 | 220.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 11.6 | 11.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 11.6 | 81.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 11.6 | 11.6 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 11.5 | 69.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 11.4 | 171.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 11.4 | 34.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 11.3 | 56.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 11.3 | 45.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 11.3 | 56.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 11.3 | 67.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 11.3 | 33.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 11.3 | 33.9 | GO:0018158 | protein oxidation(GO:0018158) |
| 11.3 | 237.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 11.3 | 67.6 | GO:0030421 | defecation(GO:0030421) |
| 11.2 | 101.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 11.2 | 33.7 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 11.2 | 22.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 11.2 | 11.2 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 11.2 | 123.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 11.2 | 33.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 11.1 | 11.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 11.1 | 88.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 11.1 | 33.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 11.1 | 33.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 11.1 | 33.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 11.0 | 11.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 10.9 | 54.7 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 10.9 | 43.6 | GO:0016240 | autophagosome docking(GO:0016240) |
| 10.9 | 21.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 10.9 | 54.5 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 10.9 | 54.4 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 10.9 | 43.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 10.9 | 43.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 10.8 | 75.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 10.8 | 43.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic organ morphogenesis(GO:0048563) |
| 10.8 | 119.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 10.8 | 54.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 10.8 | 32.4 | GO:0060166 | olfactory pit development(GO:0060166) |
| 10.8 | 10.8 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 10.7 | 53.4 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 10.6 | 21.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 10.6 | 563.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 10.6 | 21.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 10.6 | 10.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 10.5 | 31.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 10.5 | 52.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 10.4 | 104.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 10.3 | 20.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 10.3 | 41.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 10.3 | 1043.0 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 10.3 | 20.6 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 10.3 | 92.4 | GO:0009249 | protein lipoylation(GO:0009249) |
| 10.3 | 30.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 10.3 | 51.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 10.2 | 225.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 10.2 | 245.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 10.2 | 61.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 10.2 | 112.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 10.2 | 10.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 10.2 | 40.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 10.2 | 40.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 10.1 | 20.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 10.1 | 30.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 10.1 | 10.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 10.0 | 130.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 10.0 | 20.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
| 10.0 | 40.0 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 10.0 | 80.0 | GO:0002934 | desmosome organization(GO:0002934) |
| 10.0 | 99.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 10.0 | 19.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 9.9 | 39.7 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 9.9 | 9.9 | GO:0003383 | apical constriction(GO:0003383) |
| 9.9 | 19.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 9.9 | 29.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 9.8 | 29.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 9.8 | 29.4 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 9.8 | 29.4 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 9.8 | 29.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 9.7 | 19.5 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 9.7 | 9.7 | GO:1903204 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 9.7 | 29.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 9.7 | 38.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 9.7 | 96.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 9.6 | 19.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 9.6 | 19.2 | GO:0048478 | replication fork protection(GO:0048478) |
| 9.6 | 124.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 9.5 | 114.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 9.5 | 9.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 9.5 | 38.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 9.5 | 37.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 9.5 | 28.4 | GO:0050894 | determination of affect(GO:0050894) |
| 9.4 | 9.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 9.4 | 56.5 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 9.4 | 56.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 9.3 | 28.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 9.3 | 18.6 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
| 9.2 | 92.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 9.2 | 27.7 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 9.2 | 18.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 9.2 | 55.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 9.2 | 430.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 9.1 | 9.1 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 9.1 | 36.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 9.1 | 18.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 9.1 | 73.0 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 9.1 | 27.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 9.1 | 54.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 9.1 | 99.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 9.0 | 18.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 9.0 | 27.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 9.0 | 27.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 9.0 | 27.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 9.0 | 108.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 9.0 | 225.5 | GO:0051031 | tRNA transport(GO:0051031) |
| 9.0 | 495.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 9.0 | 18.0 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 9.0 | 62.9 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 8.9 | 35.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 8.9 | 8.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 8.9 | 26.7 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 8.9 | 106.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 8.8 | 35.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 8.8 | 17.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 8.8 | 8.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 8.8 | 8.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 8.7 | 8.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 8.7 | 17.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 8.7 | 26.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 8.7 | 8.7 | GO:0010039 | response to iron ion(GO:0010039) |
| 8.7 | 60.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 8.7 | 225.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 8.7 | 121.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 8.6 | 17.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 8.6 | 25.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) negative regulation of immunological synapse formation(GO:2000521) |
| 8.5 | 76.7 | GO:0045116 | protein neddylation(GO:0045116) |
| 8.5 | 42.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 8.5 | 33.9 | GO:0006983 | ER overload response(GO:0006983) |
| 8.5 | 25.4 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 8.5 | 8.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 8.5 | 59.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 8.4 | 16.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 8.4 | 151.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 8.4 | 25.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 8.3 | 33.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 8.3 | 8.3 | GO:0006826 | iron ion transport(GO:0006826) |
| 8.3 | 25.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 8.3 | 49.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 8.3 | 41.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 8.2 | 16.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 8.2 | 8.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 8.2 | 41.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 8.2 | 24.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 8.1 | 16.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 8.1 | 105.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 8.1 | 48.7 | GO:0042262 | DNA protection(GO:0042262) |
| 8.1 | 16.2 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 8.0 | 88.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 8.0 | 48.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 8.0 | 87.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 8.0 | 63.8 | GO:0042407 | cristae formation(GO:0042407) |
| 8.0 | 31.9 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 7.9 | 158.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 7.9 | 491.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 7.9 | 39.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 7.9 | 47.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 7.9 | 7.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 7.9 | 126.5 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 7.9 | 23.7 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 7.9 | 39.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 7.9 | 31.6 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 7.9 | 7.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 7.9 | 94.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 7.8 | 7.8 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 7.8 | 23.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 7.8 | 7.8 | GO:0015677 | copper ion import(GO:0015677) |
| 7.8 | 23.4 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 7.8 | 31.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 7.8 | 15.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 7.7 | 23.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 7.7 | 138.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 7.7 | 38.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 7.6 | 15.3 | GO:0006788 | heme oxidation(GO:0006788) |
| 7.6 | 45.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 7.6 | 30.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 7.5 | 90.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 7.5 | 60.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 7.5 | 22.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 7.5 | 30.0 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 7.5 | 157.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 7.5 | 7.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 7.5 | 22.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 7.5 | 14.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 7.4 | 14.9 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 7.4 | 29.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 7.4 | 22.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 7.3 | 58.8 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 7.3 | 7.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 7.3 | 44.0 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 7.3 | 29.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 7.3 | 29.1 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 7.3 | 7.3 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 7.3 | 14.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 7.3 | 36.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 7.2 | 21.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 7.2 | 57.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 7.2 | 28.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 7.2 | 14.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 7.1 | 235.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 7.1 | 14.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 7.1 | 28.3 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 7.0 | 28.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 7.0 | 21.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 7.0 | 41.9 | GO:0044351 | macropinocytosis(GO:0044351) |
| 7.0 | 13.9 | GO:0007369 | gastrulation(GO:0007369) |
| 7.0 | 34.8 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 7.0 | 7.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 7.0 | 48.7 | GO:0030091 | protein repair(GO:0030091) |
| 6.9 | 27.7 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 6.9 | 110.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 6.9 | 41.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 6.9 | 41.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 6.8 | 41.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 6.8 | 41.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 6.8 | 95.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 6.8 | 40.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 6.8 | 20.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 6.8 | 6.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 6.8 | 27.1 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 6.8 | 33.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 6.7 | 6.7 | GO:0061308 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
| 6.7 | 60.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 6.7 | 13.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 6.7 | 13.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 6.6 | 113.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 6.6 | 33.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 6.6 | 39.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 6.6 | 6.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 6.6 | 39.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 6.6 | 19.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 6.6 | 19.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 6.5 | 26.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 6.5 | 45.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 6.5 | 26.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 6.5 | 25.9 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 6.5 | 123.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 6.5 | 19.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 6.4 | 6.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 6.4 | 32.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 6.4 | 51.4 | GO:0061042 | vascular wound healing(GO:0061042) |
| 6.4 | 25.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 6.4 | 31.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 6.4 | 12.8 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 6.4 | 19.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 6.4 | 159.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 6.4 | 25.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 6.3 | 25.4 | GO:0048102 | autophagic cell death(GO:0048102) |
| 6.3 | 25.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 6.3 | 31.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 6.3 | 25.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 6.3 | 18.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 6.3 | 37.7 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 6.3 | 106.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 6.3 | 43.9 | GO:0046689 | response to mercury ion(GO:0046689) |
| 6.2 | 37.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 6.2 | 12.5 | GO:0071030 | generation of catalytic spliceosome for second transesterification step(GO:0000350) nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 6.2 | 143.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 6.2 | 24.8 | GO:0070836 | caveola assembly(GO:0070836) |
| 6.2 | 12.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 6.2 | 104.7 | GO:0006465 | signal peptide processing(GO:0006465) |
| 6.2 | 18.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 6.2 | 92.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 6.1 | 24.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 6.1 | 18.3 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 6.1 | 30.5 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 6.1 | 42.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 6.1 | 6.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 6.0 | 72.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 6.0 | 12.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 6.0 | 60.3 | GO:0060056 | mammary gland involution(GO:0060056) |
| 6.0 | 18.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 6.0 | 18.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 6.0 | 54.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 6.0 | 18.0 | GO:0019079 | viral genome replication(GO:0019079) |
| 5.9 | 17.8 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 5.9 | 65.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 5.9 | 11.8 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 5.9 | 5.9 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
| 5.9 | 41.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 5.9 | 70.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 5.9 | 23.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 5.9 | 46.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 5.9 | 421.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
| 5.8 | 29.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 5.8 | 5.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 5.7 | 17.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 5.7 | 11.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 5.7 | 96.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 5.7 | 39.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 5.7 | 5.7 | GO:1903659 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
| 5.7 | 22.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 5.7 | 11.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 5.7 | 22.6 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 5.7 | 28.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 5.6 | 5.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 5.6 | 5.6 | GO:0007549 | dosage compensation(GO:0007549) |
| 5.6 | 5.6 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 5.6 | 27.8 | GO:0033216 | ferric iron import(GO:0033216) |
| 5.5 | 22.1 | GO:0060849 | radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 5.5 | 22.1 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 5.5 | 16.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 5.5 | 71.2 | GO:0006101 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
| 5.5 | 420.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 5.4 | 65.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 5.4 | 32.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 5.4 | 16.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 5.4 | 162.3 | GO:0006414 | translational elongation(GO:0006414) |
| 5.4 | 5.4 | GO:0051884 | regulation of anagen(GO:0051884) |
| 5.4 | 32.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 5.4 | 129.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 5.4 | 194.2 | GO:0035329 | hippo signaling(GO:0035329) |
| 5.4 | 80.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 5.4 | 5.4 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
| 5.4 | 21.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 5.4 | 43.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 5.4 | 16.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 5.3 | 16.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 5.3 | 85.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 5.3 | 63.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 5.3 | 5.3 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 5.3 | 26.4 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 5.2 | 26.2 | GO:0001302 | replicative cell aging(GO:0001302) |
| 5.2 | 26.2 | GO:0060356 | leucine import(GO:0060356) |
| 5.2 | 15.7 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 5.2 | 15.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
| 5.2 | 15.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 5.2 | 41.2 | GO:0009414 | response to water deprivation(GO:0009414) |
| 5.1 | 20.6 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 5.1 | 82.1 | GO:0006415 | translational termination(GO:0006415) |
| 5.1 | 41.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 5.1 | 25.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 5.1 | 10.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 5.1 | 30.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 5.1 | 5.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 5.1 | 5.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 5.1 | 10.2 | GO:0051795 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
| 5.1 | 50.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 5.1 | 15.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 5.1 | 71.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 5.1 | 20.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 5.1 | 30.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 5.0 | 472.7 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 5.0 | 10.0 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 5.0 | 274.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 5.0 | 59.6 | GO:0009415 | response to water(GO:0009415) |
| 5.0 | 14.9 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 4.9 | 34.6 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 4.9 | 4.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 4.9 | 14.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 4.9 | 9.7 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 4.9 | 34.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 4.9 | 14.6 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 4.8 | 150.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 4.8 | 14.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 4.8 | 19.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 4.8 | 28.8 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 4.8 | 4.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 4.8 | 9.6 | GO:1904504 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 4.8 | 9.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 4.7 | 32.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 4.6 | 23.2 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 4.6 | 18.6 | GO:0030242 | pexophagy(GO:0030242) |
| 4.6 | 23.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 4.6 | 13.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 4.6 | 97.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 4.6 | 4.6 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 4.6 | 82.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 4.6 | 36.8 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 4.6 | 23.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 4.6 | 18.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 4.6 | 77.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 4.5 | 163.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 4.5 | 9.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 4.5 | 4.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 4.5 | 27.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 4.5 | 40.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 4.5 | 4.5 | GO:0010041 | response to iron(III) ion(GO:0010041) |
| 4.5 | 13.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 4.5 | 45.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 4.5 | 31.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 4.5 | 40.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 4.5 | 17.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 4.5 | 8.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 4.4 | 84.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 4.4 | 8.9 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 4.4 | 39.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 4.4 | 13.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 4.4 | 22.0 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 4.4 | 30.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 4.4 | 4.4 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 4.4 | 13.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 4.3 | 8.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 4.3 | 12.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 4.3 | 25.9 | GO:0032060 | bleb assembly(GO:0032060) |
| 4.3 | 4.3 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
| 4.3 | 4.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 4.3 | 4.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 4.2 | 16.9 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 4.2 | 4.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 4.2 | 71.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 4.2 | 16.8 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 4.2 | 154.4 | GO:0045214 | sarcomere organization(GO:0045214) |
| 4.2 | 12.5 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 4.1 | 20.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 4.1 | 24.8 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 4.1 | 24.8 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 4.1 | 8.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 4.1 | 4.1 | GO:0010458 | exit from mitosis(GO:0010458) |
| 4.1 | 4.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 4.1 | 4.1 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 4.1 | 36.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 4.0 | 16.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 4.0 | 40.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 4.0 | 28.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 4.0 | 20.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 4.0 | 8.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
| 4.0 | 12.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 4.0 | 4.0 | GO:0045191 | regulation of isotype switching(GO:0045191) |
| 4.0 | 23.9 | GO:0051451 | myoblast migration(GO:0051451) |
| 4.0 | 15.9 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
| 3.9 | 15.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 3.9 | 215.8 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 3.9 | 86.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 3.9 | 7.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 3.9 | 74.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 3.9 | 46.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 3.9 | 19.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 3.9 | 50.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 3.9 | 3.9 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 3.9 | 7.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 3.9 | 23.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 3.9 | 19.3 | GO:0015791 | polyol transport(GO:0015791) |
| 3.9 | 77.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 3.8 | 3.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 3.8 | 23.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 3.8 | 3.8 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 3.8 | 15.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 3.8 | 26.6 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 3.8 | 11.4 | GO:0006574 | valine catabolic process(GO:0006574) |
| 3.8 | 15.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 3.8 | 22.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 3.8 | 11.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 3.8 | 15.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 3.8 | 30.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 3.7 | 14.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 3.7 | 733.1 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 3.7 | 11.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 3.7 | 14.8 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 3.7 | 7.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 3.7 | 103.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 3.7 | 40.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 3.7 | 69.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 3.7 | 33.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 3.6 | 7.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 3.6 | 90.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 3.6 | 7.3 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 3.6 | 7.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 3.6 | 7.2 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 3.6 | 14.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 3.6 | 50.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 3.6 | 14.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 3.6 | 3.6 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 3.6 | 14.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 3.5 | 21.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 3.5 | 3.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 3.5 | 7.1 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 3.5 | 17.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 3.5 | 10.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 3.5 | 49.0 | GO:0006825 | copper ion transport(GO:0006825) |
| 3.5 | 3.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 3.5 | 45.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 3.5 | 117.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 3.4 | 10.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 3.4 | 6.9 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 3.4 | 10.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 3.4 | 6.8 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 3.4 | 3.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 3.4 | 6.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 3.4 | 10.2 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 3.4 | 16.9 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 3.4 | 10.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 3.4 | 6.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 3.4 | 26.9 | GO:0038065 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 3.4 | 16.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 3.3 | 6.7 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 3.3 | 50.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 3.3 | 10.0 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 3.3 | 6.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 3.3 | 9.9 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 3.3 | 33.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 3.3 | 3.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 3.3 | 9.9 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 3.3 | 69.0 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 3.3 | 45.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 3.3 | 3.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 3.2 | 16.2 | GO:0070383 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 3.2 | 12.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 3.2 | 29.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 3.2 | 3.2 | GO:0040031 | snRNA modification(GO:0040031) |
| 3.2 | 6.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 3.2 | 6.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 3.2 | 6.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 3.2 | 25.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 3.1 | 15.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 3.1 | 53.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 3.1 | 15.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 3.1 | 130.9 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 3.1 | 40.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 3.1 | 9.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 3.1 | 6.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 3.1 | 24.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 3.0 | 12.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 3.0 | 18.2 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 3.0 | 3.0 | GO:0043473 | pigmentation(GO:0043473) |
| 3.0 | 21.0 | GO:0007379 | segment specification(GO:0007379) |
| 3.0 | 3.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 3.0 | 12.0 | GO:0035973 | aggrephagy(GO:0035973) |
| 3.0 | 12.0 | GO:0006771 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
| 3.0 | 35.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 3.0 | 3.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 3.0 | 141.7 | GO:0006413 | translational initiation(GO:0006413) |
| 2.9 | 5.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 2.9 | 2.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 2.9 | 2.9 | GO:0043366 | beta selection(GO:0043366) |
| 2.9 | 2.9 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
| 2.9 | 5.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 2.9 | 2.9 | GO:0033483 | gas homeostasis(GO:0033483) |
| 2.9 | 14.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 2.9 | 23.1 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
| 2.9 | 86.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 2.9 | 8.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 2.9 | 11.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 2.9 | 2.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 2.9 | 17.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 2.8 | 2.8 | GO:0060242 | contact inhibition(GO:0060242) |
| 2.8 | 11.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 2.8 | 5.6 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 2.8 | 22.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 2.8 | 5.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 2.8 | 8.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 2.8 | 41.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 2.8 | 8.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 2.8 | 19.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 2.8 | 5.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 2.8 | 96.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 2.7 | 2.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 2.7 | 5.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 2.7 | 21.9 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 2.7 | 5.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 2.7 | 10.9 | GO:0007276 | gamete generation(GO:0007276) |
| 2.7 | 24.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 2.7 | 142.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 2.7 | 76.2 | GO:0090383 | phagosome acidification(GO:0090383) |
| 2.7 | 16.3 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 2.7 | 40.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
| 2.7 | 2.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 2.7 | 18.9 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 2.7 | 2.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 2.7 | 37.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 2.7 | 8.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 2.7 | 2.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 2.7 | 27.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 2.7 | 13.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 2.7 | 18.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 2.7 | 35.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 2.7 | 24.1 | GO:0051923 | sulfation(GO:0051923) |
| 2.7 | 32.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 2.7 | 8.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 2.6 | 50.3 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
| 2.6 | 7.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 2.6 | 7.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 2.6 | 5.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 2.6 | 15.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 2.6 | 10.3 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 2.6 | 5.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 2.6 | 10.3 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
| 2.6 | 5.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
| 2.6 | 5.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 2.6 | 12.8 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 2.6 | 5.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 2.5 | 45.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 2.5 | 7.6 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 2.5 | 22.7 | GO:0048069 | eye pigmentation(GO:0048069) |
| 2.5 | 22.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 2.5 | 2.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 2.5 | 40.0 | GO:0031639 | plasminogen activation(GO:0031639) |
| 2.5 | 12.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 2.5 | 2.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 2.5 | 17.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 2.5 | 88.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 2.4 | 19.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 2.4 | 43.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 2.4 | 2.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 2.4 | 2.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 2.4 | 21.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 2.4 | 4.8 | GO:0070269 | pyroptosis(GO:0070269) |
| 2.4 | 31.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 2.4 | 7.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 2.4 | 21.3 | GO:0030261 | chromosome condensation(GO:0030261) |
| 2.4 | 23.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 2.4 | 11.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 2.3 | 21.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 2.3 | 2.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 2.3 | 4.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 2.3 | 2.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 2.3 | 18.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 2.3 | 13.7 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 2.3 | 54.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 2.3 | 20.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 2.3 | 13.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 2.3 | 15.8 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 2.3 | 36.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 2.3 | 9.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 2.3 | 49.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 2.3 | 22.5 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 2.2 | 6.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 2.2 | 13.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 2.2 | 4.5 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 2.2 | 98.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 2.2 | 35.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 2.2 | 8.9 | GO:0035904 | aorta development(GO:0035904) |
| 2.2 | 6.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 2.2 | 13.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 2.2 | 15.5 | GO:0051231 | spindle elongation(GO:0051231) |
| 2.2 | 6.6 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 2.2 | 15.5 | GO:0009650 | UV protection(GO:0009650) |
| 2.2 | 15.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 2.2 | 4.4 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 2.2 | 8.8 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 2.2 | 6.6 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 2.2 | 15.3 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 2.2 | 19.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 2.2 | 2.2 | GO:0060157 | urinary bladder development(GO:0060157) |
| 2.2 | 4.3 | GO:0090382 | phagosome maturation(GO:0090382) |
| 2.2 | 10.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 2.2 | 34.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 2.2 | 8.6 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 2.1 | 23.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 2.1 | 12.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 2.1 | 6.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 2.1 | 2.1 | GO:0034381 | plasma lipoprotein particle clearance(GO:0034381) |
| 2.1 | 14.4 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 2.0 | 42.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 2.0 | 4.1 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 2.0 | 4.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 2.0 | 81.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 2.0 | 6.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 2.0 | 8.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 2.0 | 13.9 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 2.0 | 4.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 2.0 | 19.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 2.0 | 39.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 2.0 | 7.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 2.0 | 3.9 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
| 1.9 | 29.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.9 | 5.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 1.9 | 5.8 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.9 | 36.7 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 1.9 | 7.6 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.9 | 9.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 1.9 | 7.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 1.9 | 9.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 1.9 | 7.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 1.9 | 16.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 1.9 | 1.9 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 1.9 | 33.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 1.8 | 9.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 1.8 | 97.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
| 1.8 | 9.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 1.8 | 1.8 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 1.8 | 1.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 1.8 | 45.5 | GO:0015893 | drug transport(GO:0015893) |
| 1.8 | 9.1 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 1.8 | 3.6 | GO:0035989 | tendon development(GO:0035989) |
| 1.8 | 1.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.8 | 1.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 1.8 | 16.0 | GO:0030728 | ovulation(GO:0030728) |
| 1.8 | 12.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.8 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 1.8 | 5.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 1.8 | 14.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 1.7 | 6.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.7 | 51.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 1.7 | 15.5 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 1.7 | 1.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 1.7 | 6.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.7 | 6.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 1.7 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 1.7 | 5.1 | GO:0035803 | egg coat formation(GO:0035803) |
| 1.7 | 11.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 1.7 | 1.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 1.7 | 6.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 1.7 | 3.3 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 1.7 | 1.7 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 1.7 | 15.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.7 | 1.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 1.6 | 74.1 | GO:0051225 | spindle assembly(GO:0051225) |
| 1.6 | 19.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 1.6 | 13.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 1.6 | 1.6 | GO:0061009 | common bile duct development(GO:0061009) |
| 1.6 | 1.6 | GO:0009445 | putrescine metabolic process(GO:0009445) |
| 1.6 | 1.6 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
| 1.5 | 6.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 1.5 | 9.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 1.5 | 6.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 1.5 | 10.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.5 | 33.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.5 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.5 | 6.0 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 1.5 | 3.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.5 | 3.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.5 | 3.0 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 1.5 | 3.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 1.5 | 29.9 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 1.5 | 1.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.5 | 3.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 1.5 | 3.0 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
| 1.5 | 2.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 1.5 | 2.9 | GO:0044531 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 1.4 | 2.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 1.4 | 4.3 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 1.4 | 19.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 1.4 | 1.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 1.4 | 4.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.4 | 23.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 1.4 | 16.7 | GO:0016180 | snRNA processing(GO:0016180) |
| 1.4 | 8.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 1.4 | 8.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.4 | 2.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.4 | 6.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 1.4 | 2.7 | GO:0001878 | response to yeast(GO:0001878) |
| 1.4 | 17.7 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 1.3 | 46.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 1.3 | 5.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 1.3 | 5.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.3 | 5.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 1.3 | 3.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.3 | 14.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 1.3 | 9.0 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.3 | 10.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 1.3 | 8.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 1.3 | 1.3 | GO:0009648 | photoperiodism(GO:0009648) |
| 1.3 | 7.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 1.3 | 15.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 1.3 | 1.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 1.2 | 2.5 | GO:0042026 | protein refolding(GO:0042026) |
| 1.2 | 2.5 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
| 1.2 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.2 | 15.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 1.2 | 9.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 1.2 | 15.8 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 1.2 | 6.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 1.2 | 4.8 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 1.2 | 16.5 | GO:0008228 | opsonization(GO:0008228) |
| 1.2 | 11.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 1.2 | 7.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.2 | 15.0 | GO:0031648 | protein destabilization(GO:0031648) |
| 1.1 | 5.7 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
| 1.1 | 3.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.1 | 6.8 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 1.1 | 1.1 | GO:0061010 | gall bladder development(GO:0061010) |
| 1.1 | 14.5 | GO:0046688 | response to copper ion(GO:0046688) |
| 1.1 | 4.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.1 | 3.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 1.1 | 1.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.1 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.1 | 3.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 1.1 | 3.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 1.1 | 2.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.1 | 39.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 1.1 | 1.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 1.1 | 1.1 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 1.1 | 3.2 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
| 1.1 | 2.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
| 1.0 | 1.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
| 1.0 | 6.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 1.0 | 5.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 1.0 | 2.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 1.0 | 1.0 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
| 1.0 | 1.0 | GO:0060438 | trachea development(GO:0060438) |
| 0.9 | 2.8 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.9 | 1.9 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.9 | 2.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.9 | 22.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.9 | 48.7 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.9 | 0.9 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.9 | 5.5 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.9 | 3.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.9 | 7.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.9 | 1.8 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.9 | 5.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.9 | 9.8 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.9 | 10.5 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.9 | 66.6 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.9 | 14.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.9 | 5.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.8 | 4.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.8 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.8 | 2.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.8 | 1.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.8 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.8 | 0.8 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.8 | 17.7 | GO:0007569 | cell aging(GO:0007569) |
| 0.8 | 0.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.8 | 4.7 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.8 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.8 | 3.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.8 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.8 | 8.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.8 | 6.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.8 | 4.6 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
| 0.8 | 1.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.8 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.8 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.7 | 2.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
| 0.7 | 2.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.7 | 2.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.7 | 0.7 | GO:0055093 | response to hyperoxia(GO:0055093) |
| 0.7 | 5.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.7 | 1.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.7 | 1.4 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) |
| 0.7 | 6.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.7 | 2.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.7 | 2.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 | 1.4 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.7 | 10.8 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.7 | 2.7 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 0.7 | 16.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.7 | 30.7 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.7 | 25.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.7 | 4.6 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.7 | 5.3 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.7 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.7 | 2.0 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.6 | 9.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.6 | 3.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.6 | 2.6 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.6 | 2.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 | 8.9 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.6 | 3.8 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.6 | 1.9 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.6 | 1.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.6 | 1.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.6 | 1.9 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.6 | 2.5 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.6 | 6.1 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.6 | 10.3 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.6 | 1.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.6 | 5.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.6 | 56.1 | GO:0070268 | cornification(GO:0070268) |
| 0.6 | 2.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.6 | 8.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.6 | 2.9 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.6 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.6 | 9.5 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.6 | 1.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.1 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
| 0.5 | 3.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 2.7 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.5 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.5 | 4.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.5 | 1.0 | GO:0038111 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.5 | 1.0 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
| 0.5 | 1.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.5 | 3.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.5 | 1.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.5 | 1.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 | 2.9 | GO:0014823 | response to activity(GO:0014823) |
| 0.5 | 1.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 | 3.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.5 | 1.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.5 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.5 | 1.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.5 | 13.3 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.5 | 0.5 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.5 | 1.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 | 1.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.5 | 0.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.5 | 1.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.4 | 5.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.4 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.4 | 11.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.4 | 0.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.4 | 4.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.4 | 1.6 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.4 | 1.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.4 | 6.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.4 | 8.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.4 | 8.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.4 | 0.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.4 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 | 4.0 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.3 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.3 | 1.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
| 0.3 | 1.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.3 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 | 4.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 0.6 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.3 | 1.5 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.3 | 2.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.3 | 0.6 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.3 | 4.0 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.3 | 0.3 | GO:0033006 | mast cell mediated immunity(GO:0002448) regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.3 | 0.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.3 | 1.9 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.9 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 5.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.2 | 1.5 | GO:0019054 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 | 1.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.2 | 2.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.2 | 0.6 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.2 | 0.8 | GO:1904588 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.2 | 49.2 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.2 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.2 | 0.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
| 0.2 | 0.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.1 | 1.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.1 | 1.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.1 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 1.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 0.2 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.1 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 | 0.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 0.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 0.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.0 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus development(GO:0060482) |
| 0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 59.5 | 238.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 52.8 | 158.4 | GO:0031523 | Myb complex(GO:0031523) |
| 50.2 | 250.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 46.1 | 138.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 44.1 | 529.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 41.0 | 204.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 40.5 | 242.9 | GO:0005683 | U7 snRNP(GO:0005683) |
| 35.9 | 143.6 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 35.1 | 281.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 35.1 | 105.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 33.9 | 305.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 33.3 | 599.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 32.2 | 32.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 30.9 | 123.8 | GO:0000811 | GINS complex(GO:0000811) |
| 30.2 | 271.5 | GO:0000125 | PCAF complex(GO:0000125) |
| 29.3 | 205.3 | GO:0016589 | NURF complex(GO:0016589) |
| 29.3 | 175.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 29.0 | 173.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 29.0 | 260.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 28.6 | 114.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 28.6 | 171.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 28.5 | 142.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 28.0 | 364.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 28.0 | 139.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 27.8 | 83.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 27.5 | 165.0 | GO:0001740 | Barr body(GO:0001740) |
| 27.4 | 82.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 27.2 | 108.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 26.9 | 80.7 | GO:0030689 | Noc complex(GO:0030689) |
| 26.3 | 131.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 26.2 | 157.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 26.0 | 130.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 25.6 | 102.3 | GO:0070985 | TFIIK complex(GO:0070985) |
| 25.3 | 75.9 | GO:0018444 | translation release factor complex(GO:0018444) |
| 24.8 | 198.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 24.2 | 169.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 23.9 | 167.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 23.6 | 117.9 | GO:0001940 | male pronucleus(GO:0001940) |
| 23.4 | 748.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 23.0 | 229.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 22.8 | 68.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 22.8 | 68.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 22.4 | 89.5 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 22.3 | 602.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 21.7 | 217.4 | GO:0000796 | condensin complex(GO:0000796) |
| 21.5 | 215.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 21.3 | 63.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 21.2 | 254.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 20.6 | 41.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 20.6 | 246.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 20.5 | 61.6 | GO:0044393 | microspike(GO:0044393) |
| 20.5 | 102.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 20.4 | 81.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 20.4 | 81.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 19.9 | 756.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 19.8 | 59.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 19.5 | 136.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 19.3 | 96.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 19.1 | 153.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 19.1 | 153.0 | GO:0042382 | paraspeckles(GO:0042382) |
| 18.8 | 56.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 18.8 | 207.2 | GO:0005688 | U6 snRNP(GO:0005688) |
| 18.8 | 206.7 | GO:0034709 | methylosome(GO:0034709) |
| 18.7 | 93.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 18.6 | 37.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 18.6 | 55.7 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 18.2 | 345.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 18.2 | 272.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 18.1 | 289.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 17.8 | 231.9 | GO:0042555 | MCM complex(GO:0042555) |
| 17.8 | 53.5 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 17.8 | 89.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 17.6 | 88.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 17.6 | 123.0 | GO:0031415 | NatA complex(GO:0031415) |
| 17.4 | 139.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 17.2 | 189.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 17.1 | 908.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 17.1 | 171.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 16.8 | 487.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 16.7 | 317.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 16.6 | 66.5 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 16.6 | 49.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 16.5 | 165.5 | GO:0090543 | Flemming body(GO:0090543) |
| 16.0 | 16.0 | GO:0005687 | U4 snRNP(GO:0005687) |
| 16.0 | 48.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 16.0 | 127.8 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 15.9 | 47.8 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 15.9 | 79.6 | GO:0033503 | HULC complex(GO:0033503) |
| 15.8 | 47.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 15.7 | 109.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 15.6 | 171.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 15.5 | 15.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 15.5 | 108.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 15.4 | 46.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 15.4 | 77.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 15.3 | 76.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 15.1 | 151.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 15.1 | 241.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 15.0 | 44.9 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 15.0 | 59.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 14.9 | 59.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 14.8 | 74.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 14.8 | 444.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 14.5 | 116.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 14.5 | 72.5 | GO:0032449 | CBM complex(GO:0032449) |
| 14.4 | 100.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 14.4 | 201.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 14.3 | 57.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 14.2 | 57.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 14.1 | 183.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 14.1 | 84.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 14.0 | 56.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 13.9 | 41.8 | GO:0034455 | t-UTP complex(GO:0034455) |
| 13.6 | 489.8 | GO:0000502 | proteasome complex(GO:0000502) |
| 13.4 | 254.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 13.3 | 79.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 13.2 | 39.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 13.1 | 131.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 13.1 | 65.4 | GO:0032021 | NELF complex(GO:0032021) |
| 13.0 | 273.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 12.9 | 116.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 12.9 | 38.7 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 12.8 | 38.3 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 12.6 | 214.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 12.6 | 100.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 12.5 | 137.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 12.5 | 261.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 12.5 | 149.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 12.5 | 12.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 12.3 | 123.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 12.3 | 159.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 12.3 | 36.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 12.3 | 24.5 | GO:0043203 | axon hillock(GO:0043203) |
| 12.2 | 1327.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 12.2 | 48.6 | GO:1990357 | terminal web(GO:1990357) |
| 12.1 | 85.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 12.1 | 60.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 12.0 | 60.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 12.0 | 47.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 11.9 | 47.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 11.9 | 249.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 11.6 | 58.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 11.5 | 322.0 | GO:0031143 | pseudopodium(GO:0031143) |
| 11.4 | 11.4 | GO:0001652 | granular component(GO:0001652) |
| 11.4 | 147.9 | GO:0044754 | autolysosome(GO:0044754) |
| 11.4 | 113.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 11.4 | 34.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 11.2 | 11.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 10.9 | 32.8 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 10.9 | 260.9 | GO:0071564 | npBAF complex(GO:0071564) |
| 10.8 | 43.3 | GO:0031905 | early endosome lumen(GO:0031905) |
| 10.7 | 74.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 10.7 | 96.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 10.7 | 74.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 10.7 | 85.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 10.6 | 42.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 10.6 | 63.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 10.5 | 73.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 10.4 | 31.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 10.4 | 103.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 10.3 | 82.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 10.3 | 71.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 10.3 | 195.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 10.2 | 30.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 10.2 | 152.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 10.1 | 40.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 10.1 | 1488.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 10.1 | 20.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 10.1 | 20.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 10.1 | 30.3 | GO:1990393 | 3M complex(GO:1990393) |
| 10.0 | 381.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 10.0 | 60.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 10.0 | 109.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 9.9 | 39.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 9.9 | 296.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 9.7 | 77.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 9.7 | 173.8 | GO:0005685 | U1 snRNP(GO:0005685) |
| 9.5 | 143.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 9.5 | 123.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 9.5 | 542.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 9.5 | 113.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 9.4 | 66.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 9.4 | 18.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
| 9.4 | 1488.2 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 9.3 | 215.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 9.3 | 83.9 | GO:0097433 | dense body(GO:0097433) |
| 9.3 | 46.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 9.1 | 63.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 9.0 | 54.1 | GO:0030904 | retromer complex(GO:0030904) |
| 9.0 | 54.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 9.0 | 26.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 8.9 | 80.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 8.9 | 71.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 8.7 | 174.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 8.7 | 8.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 8.7 | 17.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 8.6 | 94.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 8.5 | 25.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 8.5 | 356.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 8.4 | 479.7 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 8.3 | 33.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 8.3 | 728.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 8.2 | 16.4 | GO:0032432 | actin filament bundle(GO:0032432) |
| 8.1 | 32.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 8.1 | 89.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 8.1 | 8.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 8.1 | 72.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 8.0 | 72.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 8.0 | 8.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 8.0 | 95.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 7.9 | 39.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 7.9 | 133.7 | GO:0005844 | polysome(GO:0005844) |
| 7.9 | 78.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 7.8 | 541.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 7.8 | 78.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 7.8 | 46.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 7.8 | 590.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 7.7 | 30.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 7.7 | 122.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 7.6 | 45.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 7.6 | 7.6 | GO:0097342 | ripoptosome(GO:0097342) |
| 7.6 | 22.7 | GO:0097447 | dendritic tree(GO:0097447) |
| 7.5 | 45.0 | GO:0005915 | zonula adherens(GO:0005915) |
| 7.5 | 44.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 7.4 | 74.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 7.4 | 81.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 7.3 | 58.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 7.3 | 44.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 7.3 | 51.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 7.2 | 28.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 7.2 | 50.2 | GO:0031931 | TORC1 complex(GO:0031931) |
| 7.1 | 21.4 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 7.1 | 28.5 | GO:0070938 | contractile ring(GO:0070938) |
| 7.1 | 63.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 7.0 | 49.2 | GO:0070187 | telosome(GO:0070187) |
| 7.0 | 49.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 7.0 | 84.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 7.0 | 34.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 7.0 | 20.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 7.0 | 34.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 6.9 | 20.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 6.9 | 62.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 6.9 | 13.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 6.8 | 512.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 6.8 | 61.4 | GO:0005638 | lamin filament(GO:0005638) |
| 6.7 | 6.7 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 6.7 | 6.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 6.7 | 33.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 6.7 | 552.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 6.6 | 92.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 6.6 | 39.5 | GO:0051286 | cell tip(GO:0051286) |
| 6.6 | 144.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 6.6 | 13.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 6.5 | 735.6 | GO:0016605 | PML body(GO:0016605) |
| 6.5 | 58.6 | GO:0032059 | bleb(GO:0032059) |
| 6.3 | 12.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 6.2 | 336.4 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 6.2 | 18.5 | GO:0005715 | late recombination nodule(GO:0005715) |
| 6.1 | 182.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 6.1 | 30.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 6.1 | 175.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 6.0 | 12.1 | GO:0000322 | storage vacuole(GO:0000322) |
| 6.0 | 18.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 5.9 | 35.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 5.9 | 41.2 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 5.8 | 29.0 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
| 5.8 | 11.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 5.7 | 262.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 5.7 | 34.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 5.6 | 50.4 | GO:0032039 | integrator complex(GO:0032039) |
| 5.6 | 11.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 5.6 | 39.0 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 5.5 | 43.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 5.5 | 16.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 5.4 | 10.8 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 5.4 | 2375.4 | GO:0005925 | focal adhesion(GO:0005925) |
| 5.4 | 21.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 5.3 | 5.3 | GO:0097449 | astrocyte projection(GO:0097449) |
| 5.2 | 31.4 | GO:0001520 | outer dense fiber(GO:0001520) |
| 5.2 | 115.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 5.2 | 15.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 5.2 | 31.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 5.2 | 15.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 5.1 | 25.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 5.1 | 45.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 5.0 | 90.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 5.0 | 20.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 5.0 | 129.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 5.0 | 5.0 | GO:0002102 | podosome(GO:0002102) |
| 4.9 | 63.8 | GO:0005814 | centriole(GO:0005814) |
| 4.9 | 146.9 | GO:0005840 | ribosome(GO:0005840) |
| 4.9 | 4.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 4.9 | 14.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 4.8 | 270.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 4.8 | 19.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 4.8 | 14.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 4.8 | 33.3 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 4.7 | 14.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 4.7 | 14.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 4.7 | 23.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 4.7 | 23.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 4.7 | 230.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 4.7 | 18.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 4.7 | 261.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 4.6 | 50.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 4.6 | 27.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 4.5 | 27.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 4.5 | 45.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 4.5 | 13.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 4.5 | 35.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 4.4 | 31.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 4.4 | 44.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 4.4 | 21.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 4.4 | 39.2 | GO:0097413 | Lewy body(GO:0097413) |
| 4.3 | 108.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 4.2 | 25.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 4.1 | 8.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 4.1 | 12.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 4.0 | 28.2 | GO:0010369 | chromocenter(GO:0010369) |
| 4.0 | 16.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 4.0 | 19.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 3.9 | 3.9 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 3.9 | 19.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 3.9 | 7.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 3.8 | 19.2 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 3.8 | 22.9 | GO:0000124 | SAGA complex(GO:0000124) |
| 3.8 | 41.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 3.8 | 11.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 3.8 | 7.5 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 3.7 | 546.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 3.6 | 14.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 3.6 | 101.5 | GO:1990391 | DNA repair complex(GO:1990391) |
| 3.6 | 10.7 | GO:0000145 | exocyst(GO:0000145) |
| 3.5 | 17.6 | GO:0070852 | cell body fiber(GO:0070852) |
| 3.5 | 13.9 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 3.3 | 6.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 3.3 | 19.6 | GO:0000812 | Swr1 complex(GO:0000812) |
| 3.2 | 22.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 3.2 | 57.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 3.1 | 55.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 3.0 | 3.0 | GO:0044308 | axonal spine(GO:0044308) |
| 3.0 | 11.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 2.9 | 8.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 2.9 | 29.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 2.9 | 11.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 2.9 | 51.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 2.7 | 551.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 2.7 | 24.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 2.7 | 16.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 2.7 | 83.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 2.7 | 40.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 2.7 | 58.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 2.7 | 13.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 2.6 | 13.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 2.6 | 31.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 2.6 | 7.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 2.6 | 12.9 | GO:0033263 | CORVET complex(GO:0033263) |
| 2.6 | 17.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 2.5 | 10.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 2.5 | 112.4 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 2.4 | 12.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 2.4 | 14.3 | GO:0033643 | host cell part(GO:0033643) |
| 2.4 | 97.2 | GO:0000785 | chromatin(GO:0000785) |
| 2.4 | 98.8 | GO:0045095 | keratin filament(GO:0045095) |
| 2.3 | 134.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 2.3 | 13.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 2.2 | 114.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 2.2 | 11.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 2.2 | 8.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 2.2 | 8.6 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 2.2 | 4.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 2.2 | 630.2 | GO:0005635 | nuclear envelope(GO:0005635) |
| 2.1 | 10.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 2.1 | 35.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 2.1 | 8.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 2.1 | 206.7 | GO:0042581 | specific granule(GO:0042581) |
| 2.0 | 14.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 2.0 | 14.3 | GO:0030478 | actin cap(GO:0030478) |
| 2.0 | 136.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 2.0 | 181.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 2.0 | 65.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 2.0 | 4.1 | GO:0055087 | Ski complex(GO:0055087) |
| 2.0 | 13.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 2.0 | 183.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 2.0 | 5.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 2.0 | 17.7 | GO:0016363 | nuclear matrix(GO:0016363) |
| 2.0 | 2.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 1.9 | 1.9 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 1.8 | 78.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 1.8 | 34.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 1.8 | 32.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 1.8 | 9.1 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 1.8 | 91.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 1.7 | 112.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 1.6 | 36.2 | GO:0005795 | Golgi stack(GO:0005795) |
| 1.6 | 50.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 1.6 | 32.2 | GO:0031526 | brush border membrane(GO:0031526) |
| 1.6 | 17.5 | GO:0001726 | ruffle(GO:0001726) |
| 1.6 | 18.9 | GO:0035861 | site of double-strand break(GO:0035861) |
| 1.6 | 72.4 | GO:0005811 | lipid particle(GO:0005811) |
| 1.5 | 18.4 | GO:0032040 | small-subunit processome(GO:0032040) |
| 1.5 | 4.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 1.5 | 8.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 1.4 | 4.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.4 | 2.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 1.4 | 199.9 | GO:0005819 | spindle(GO:0005819) |
| 1.4 | 3225.7 | GO:0070062 | extracellular exosome(GO:0070062) |
| 1.4 | 10.9 | GO:0005903 | brush border(GO:0005903) |
| 1.3 | 3.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 1.3 | 34.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 1.2 | 11.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 1.2 | 4.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.1 | 2.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 1.1 | 4.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.1 | 3.3 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 1.0 | 5.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 1.0 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.0 | 5.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 1.0 | 3.0 | GO:0032420 | stereocilium(GO:0032420) |
| 1.0 | 2.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.9 | 2.8 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.8 | 5.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.8 | 0.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.7 | 6.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.7 | 4.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.7 | 5.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.6 | 1.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.6 | 6.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.6 | 1.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.6 | 7.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.6 | 80.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.5 | 2.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.5 | 5.6 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.5 | 1.0 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.5 | 6.4 | GO:0032982 | myosin filament(GO:0032982) |
| 0.5 | 7.2 | GO:0043034 | costamere(GO:0043034) |
| 0.4 | 4.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.4 | 4.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.4 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
| 0.4 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.4 | 0.4 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.4 | 1.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 8.2 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 2.0 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 0.3 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.3 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 547.2 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.2 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 59.6 | 178.9 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 59.5 | 238.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 58.6 | 293.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 47.6 | 142.7 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 42.5 | 127.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 40.9 | 122.8 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 39.5 | 118.5 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 37.2 | 260.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 36.7 | 256.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 36.6 | 109.8 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 36.6 | 182.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 36.1 | 216.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 35.9 | 143.6 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 35.9 | 251.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 35.8 | 107.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 34.7 | 139.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 34.2 | 136.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 33.4 | 133.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 33.3 | 599.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 32.5 | 129.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 32.3 | 129.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 32.0 | 192.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 31.9 | 287.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 31.8 | 382.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 31.4 | 125.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 31.2 | 218.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 29.9 | 119.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 29.9 | 89.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 29.8 | 89.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 29.6 | 207.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 29.6 | 236.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 29.5 | 265.7 | GO:0015288 | porin activity(GO:0015288) |
| 29.1 | 116.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 29.1 | 87.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 28.4 | 340.7 | GO:0031386 | protein tag(GO:0031386) |
| 27.8 | 1279.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 27.8 | 111.0 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 27.3 | 109.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 27.3 | 818.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 26.9 | 134.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 26.6 | 106.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 25.3 | 75.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 25.1 | 100.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 25.1 | 75.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 24.9 | 248.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 24.8 | 74.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 24.6 | 73.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 24.5 | 98.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 24.5 | 24.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 24.5 | 122.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 24.1 | 168.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 23.8 | 71.5 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 23.5 | 94.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 23.4 | 70.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 23.3 | 46.6 | GO:0043398 | HLH domain binding(GO:0043398) |
| 23.3 | 139.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 22.8 | 68.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 22.5 | 134.9 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 22.5 | 89.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 22.3 | 22.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 21.9 | 241.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 21.8 | 21.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 21.8 | 262.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 21.8 | 65.3 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 21.1 | 126.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 20.9 | 271.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 20.8 | 41.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 20.8 | 62.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 20.8 | 166.5 | GO:0005497 | androgen binding(GO:0005497) |
| 20.5 | 225.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 20.5 | 82.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 20.5 | 736.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 20.0 | 140.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 20.0 | 159.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 19.8 | 237.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 19.6 | 117.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 19.4 | 58.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 19.2 | 57.7 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 19.0 | 57.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 18.9 | 56.8 | GO:0030984 | kininogen binding(GO:0030984) |
| 18.7 | 130.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 18.7 | 93.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 18.5 | 55.4 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 18.4 | 36.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 18.4 | 73.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 17.8 | 53.5 | GO:0000150 | recombinase activity(GO:0000150) |
| 17.7 | 212.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 17.4 | 69.8 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 17.3 | 86.7 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 17.1 | 171.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 17.1 | 136.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 17.0 | 67.9 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 16.9 | 270.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 16.9 | 16.9 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 16.9 | 50.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 16.8 | 218.0 | GO:0000339 | RNA cap binding(GO:0000339) |
| 16.7 | 100.4 | GO:0046979 | TAP2 binding(GO:0046979) |
| 16.7 | 317.0 | GO:0070628 | proteasome binding(GO:0070628) |
| 16.6 | 66.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 16.6 | 16.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 16.6 | 66.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 16.5 | 33.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 16.4 | 81.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 16.4 | 49.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 16.4 | 65.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 16.3 | 97.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 16.2 | 162.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 16.2 | 162.1 | GO:0070990 | snRNP binding(GO:0070990) |
| 16.1 | 48.3 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 16.1 | 144.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 16.0 | 160.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 15.9 | 143.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 15.9 | 111.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 15.9 | 47.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 15.8 | 47.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 15.8 | 221.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 15.8 | 63.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 15.8 | 47.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 15.8 | 78.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
| 15.7 | 31.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 15.6 | 93.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 15.4 | 61.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 15.3 | 61.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 15.1 | 60.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 15.0 | 45.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 15.0 | 15.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 15.0 | 75.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 15.0 | 74.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 14.9 | 89.6 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 14.8 | 59.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 14.8 | 118.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 14.8 | 103.7 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 14.8 | 147.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 14.7 | 58.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 14.7 | 73.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 14.7 | 58.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 14.5 | 87.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 14.5 | 14.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 14.5 | 14.5 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 14.3 | 57.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 14.3 | 156.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 14.3 | 99.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 14.3 | 270.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 14.2 | 14.2 | GO:0032427 | GBD domain binding(GO:0032427) |
| 14.2 | 99.3 | GO:0030911 | TPR domain binding(GO:0030911) |
| 14.0 | 645.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 14.0 | 56.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 14.0 | 83.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 13.9 | 41.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 13.7 | 68.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 13.7 | 68.3 | GO:0002046 | opsin binding(GO:0002046) |
| 13.6 | 2727.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 13.5 | 67.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 13.5 | 26.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 13.5 | 40.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 13.4 | 67.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 13.3 | 79.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 13.2 | 211.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 13.2 | 66.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 13.1 | 78.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 13.1 | 52.3 | GO:0005347 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
| 13.0 | 39.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 13.0 | 51.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 12.9 | 38.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 12.9 | 231.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 12.9 | 321.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 12.8 | 12.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 12.8 | 63.8 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 12.7 | 38.2 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 12.7 | 38.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 12.6 | 88.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 12.5 | 37.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 12.4 | 12.4 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 12.4 | 37.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 12.2 | 36.5 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 12.1 | 48.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 12.0 | 300.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 11.9 | 59.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 11.9 | 95.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 11.8 | 670.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 11.7 | 339.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 11.7 | 46.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 11.7 | 46.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 11.6 | 162.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 11.6 | 81.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 11.6 | 11.6 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 11.5 | 80.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 11.5 | 46.1 | GO:0043515 | kinetochore binding(GO:0043515) |
| 11.5 | 34.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 11.4 | 91.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 11.4 | 11.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 11.4 | 22.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 11.3 | 225.7 | GO:0008143 | poly(A) binding(GO:0008143) |
| 11.2 | 33.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 11.2 | 44.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 11.2 | 33.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 11.2 | 33.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 11.1 | 22.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 11.1 | 22.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 11.1 | 320.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 11.1 | 33.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 11.1 | 44.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 11.1 | 33.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 11.0 | 33.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 11.0 | 87.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 10.9 | 54.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 10.9 | 43.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 10.9 | 43.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 10.9 | 32.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 10.8 | 64.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 10.8 | 21.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 10.7 | 75.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 10.7 | 106.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 10.6 | 85.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 10.6 | 63.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 10.5 | 52.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 10.4 | 31.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 10.3 | 392.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 10.3 | 61.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 10.2 | 40.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 10.2 | 40.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 10.1 | 263.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 10.1 | 30.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 10.1 | 30.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 10.1 | 90.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 10.0 | 70.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 9.9 | 39.7 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 9.9 | 89.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 9.9 | 29.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 9.8 | 108.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 9.8 | 19.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 9.8 | 185.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 9.7 | 29.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 9.6 | 38.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 9.6 | 9.6 | GO:0043168 | anion binding(GO:0043168) |
| 9.6 | 384.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 9.6 | 28.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 9.5 | 57.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 9.5 | 275.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 9.4 | 37.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 9.4 | 226.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 9.4 | 56.5 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 9.4 | 423.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 9.4 | 47.1 | GO:0070513 | death domain binding(GO:0070513) |
| 9.4 | 84.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 9.3 | 307.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 9.3 | 55.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 9.3 | 9.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 9.2 | 9.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 9.2 | 55.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 9.2 | 36.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 9.2 | 45.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 9.1 | 27.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 9.1 | 18.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 9.1 | 127.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 9.1 | 9.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 9.0 | 27.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 9.0 | 143.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 9.0 | 44.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 8.9 | 44.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 8.9 | 35.6 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 8.9 | 35.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 8.8 | 97.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 8.8 | 105.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 8.8 | 26.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 8.8 | 70.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 8.8 | 166.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 8.7 | 43.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 8.7 | 34.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 8.7 | 87.2 | GO:0003680 | AT DNA binding(GO:0003680) |
| 8.7 | 60.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 8.7 | 52.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 8.6 | 60.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 8.6 | 51.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 8.6 | 129.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 8.6 | 17.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 8.6 | 394.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 8.5 | 51.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 8.5 | 59.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 8.5 | 25.4 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 8.4 | 33.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 8.4 | 577.4 | GO:0019003 | GDP binding(GO:0019003) |
| 8.3 | 66.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 8.3 | 16.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 8.3 | 24.9 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 8.3 | 3263.5 | GO:0045296 | cadherin binding(GO:0045296) |
| 8.3 | 41.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 8.3 | 99.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 8.3 | 322.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 8.2 | 24.7 | GO:0048030 | disaccharide binding(GO:0048030) |
| 8.2 | 24.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 8.2 | 57.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 8.1 | 48.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 8.0 | 410.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 8.0 | 16.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 8.0 | 16.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 7.9 | 47.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 7.9 | 7.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 7.9 | 23.7 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 7.9 | 31.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 7.9 | 55.0 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
| 7.8 | 7.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 7.8 | 171.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 7.8 | 31.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 7.8 | 23.4 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 7.8 | 412.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 7.8 | 69.9 | GO:0035877 | death effector domain binding(GO:0035877) |
| 7.8 | 23.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 7.8 | 31.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 7.7 | 191.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 7.7 | 23.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 7.6 | 30.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 7.6 | 22.8 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 7.6 | 22.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 7.6 | 30.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 7.6 | 45.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 7.5 | 30.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 7.5 | 82.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 7.5 | 187.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 7.5 | 14.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 7.5 | 22.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 7.5 | 7.5 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
| 7.4 | 7.4 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
| 7.4 | 111.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 7.4 | 324.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 7.3 | 21.9 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 7.3 | 124.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 7.3 | 7.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 7.3 | 80.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 7.3 | 195.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 7.2 | 159.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 7.2 | 14.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 7.2 | 14.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) glutathione disulfide oxidoreductase activity(GO:0015038) |
| 7.2 | 115.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 7.2 | 114.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 7.2 | 7.2 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
| 7.1 | 21.4 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 7.1 | 21.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 7.1 | 14.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 7.1 | 70.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 7.0 | 175.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 7.0 | 140.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 7.0 | 35.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 7.0 | 146.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 7.0 | 132.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 6.9 | 90.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 6.9 | 104.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 6.9 | 27.7 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 6.8 | 123.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 6.8 | 54.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 6.8 | 20.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 6.8 | 13.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 6.8 | 74.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 6.7 | 6.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 6.7 | 93.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 6.7 | 40.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 6.7 | 33.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 6.7 | 13.3 | GO:0043532 | angiostatin binding(GO:0043532) |
| 6.6 | 33.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 6.6 | 550.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 6.5 | 39.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 6.5 | 13.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 6.5 | 52.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 6.5 | 19.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 6.5 | 65.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 6.5 | 19.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 6.4 | 19.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 6.4 | 51.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 6.4 | 6.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 6.4 | 70.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 6.3 | 31.6 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 6.3 | 113.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 6.2 | 12.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 6.2 | 6.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 6.2 | 43.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 6.2 | 18.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 6.1 | 36.9 | GO:0034452 | dynactin binding(GO:0034452) |
| 6.1 | 86.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 6.1 | 24.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 6.1 | 12.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 6.1 | 24.3 | GO:0004335 | galactokinase activity(GO:0004335) |
| 6.1 | 12.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 6.1 | 72.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 6.0 | 6.0 | GO:0048038 | quinone binding(GO:0048038) |
| 6.0 | 12.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 6.0 | 113.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 5.9 | 41.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 5.9 | 11.8 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 5.9 | 64.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 5.9 | 35.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 5.9 | 41.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 5.9 | 134.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 5.8 | 92.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 5.8 | 46.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 5.8 | 5.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 5.7 | 268.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 5.7 | 164.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 5.7 | 22.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 5.6 | 62.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 5.6 | 16.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 5.5 | 38.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 5.5 | 5.5 | GO:0043531 | ADP binding(GO:0043531) |
| 5.5 | 16.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 5.4 | 5.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 5.4 | 32.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 5.3 | 37.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 5.3 | 111.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 5.3 | 15.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 5.3 | 10.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 5.3 | 31.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 5.3 | 10.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 5.3 | 15.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 5.2 | 10.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 5.2 | 46.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 5.2 | 31.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 5.2 | 181.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 5.1 | 20.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 5.1 | 5.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 5.1 | 25.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 5.1 | 35.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 5.1 | 25.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 5.0 | 35.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 5.0 | 140.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 5.0 | 20.0 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 5.0 | 10.0 | GO:0030552 | cAMP binding(GO:0030552) |
| 5.0 | 208.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 4.9 | 39.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 4.9 | 39.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 4.9 | 19.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 4.9 | 9.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 4.9 | 4.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 4.9 | 14.6 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 4.9 | 19.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 4.8 | 19.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 4.8 | 9.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 4.8 | 38.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 4.8 | 66.9 | GO:0005537 | mannose binding(GO:0005537) |
| 4.8 | 14.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 4.8 | 9.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 4.7 | 23.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 4.7 | 85.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 4.7 | 4.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 4.6 | 18.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 4.6 | 23.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 4.6 | 18.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 4.6 | 228.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 4.5 | 31.8 | GO:0000182 | rDNA binding(GO:0000182) |
| 4.5 | 36.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 4.5 | 4.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 4.5 | 9.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 4.5 | 58.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 4.5 | 13.6 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 4.5 | 9.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 4.5 | 17.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 4.5 | 13.4 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 4.5 | 8.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 4.4 | 8.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 4.4 | 48.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 4.4 | 21.8 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 4.4 | 30.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 4.3 | 4.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 4.2 | 17.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 4.2 | 80.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 4.2 | 4.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 4.2 | 66.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 4.2 | 12.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 4.1 | 24.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 4.1 | 12.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 4.1 | 20.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 4.1 | 12.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 4.1 | 36.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 4.0 | 16.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 4.0 | 24.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 4.0 | 124.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 4.0 | 20.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 4.0 | 31.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 4.0 | 11.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 4.0 | 316.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 3.9 | 19.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 3.9 | 15.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 3.9 | 15.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 3.9 | 309.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 3.9 | 7.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 3.9 | 3960.4 | GO:0003723 | RNA binding(GO:0003723) |
| 3.9 | 62.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 3.8 | 19.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 3.8 | 15.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 3.8 | 3.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 3.8 | 33.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 3.7 | 22.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 3.7 | 216.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 3.7 | 11.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 3.7 | 14.8 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 3.7 | 62.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 3.7 | 25.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 3.6 | 7.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 3.6 | 330.0 | GO:0042393 | histone binding(GO:0042393) |
| 3.6 | 14.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 3.6 | 49.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 3.5 | 7.0 | GO:0035326 | enhancer binding(GO:0035326) |
| 3.5 | 237.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 3.5 | 6.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 3.4 | 10.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 3.4 | 10.3 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 3.4 | 17.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 3.4 | 10.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 3.4 | 6.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 3.4 | 13.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 3.4 | 60.3 | GO:0004386 | helicase activity(GO:0004386) |
| 3.3 | 46.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 3.3 | 81.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 3.3 | 19.6 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 3.3 | 19.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 3.3 | 13.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 3.2 | 19.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 3.2 | 9.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 3.2 | 19.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 3.2 | 12.9 | GO:0043295 | glutathione binding(GO:0043295) |
| 3.2 | 22.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 3.2 | 57.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 3.2 | 467.9 | GO:0005178 | integrin binding(GO:0005178) |
| 3.2 | 12.7 | GO:0031013 | troponin I binding(GO:0031013) |
| 3.1 | 28.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 3.1 | 22.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 3.1 | 53.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 3.1 | 9.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 3.1 | 6.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 3.0 | 18.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 2.9 | 43.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 2.9 | 8.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 2.9 | 11.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 2.9 | 11.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 2.9 | 28.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 2.9 | 28.5 | GO:0031404 | chloride ion binding(GO:0031404) |
| 2.8 | 11.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 2.8 | 39.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 2.8 | 22.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 2.8 | 2.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 2.8 | 2.8 | GO:0019961 | interferon binding(GO:0019961) |
| 2.8 | 8.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 2.8 | 19.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 2.7 | 19.2 | GO:0000832 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 2.7 | 68.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 2.7 | 2.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 2.7 | 16.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 2.7 | 2.7 | GO:0050693 | LBD domain binding(GO:0050693) |
| 2.7 | 40.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 2.6 | 21.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 2.6 | 15.8 | GO:0019213 | deacetylase activity(GO:0019213) |
| 2.6 | 20.7 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
| 2.6 | 72.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 2.6 | 12.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 2.5 | 25.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 2.5 | 12.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 2.5 | 2.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 2.5 | 35.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 2.5 | 67.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 2.5 | 14.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 2.5 | 2.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 2.5 | 9.8 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 2.4 | 22.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 2.4 | 7.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 2.4 | 2.4 | GO:0097001 | ceramide binding(GO:0097001) |
| 2.4 | 4.7 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 2.3 | 151.6 | GO:0008565 | protein transporter activity(GO:0008565) |
| 2.3 | 11.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 2.3 | 6.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 2.3 | 13.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 2.3 | 11.3 | GO:0089720 | caspase binding(GO:0089720) |
| 2.3 | 253.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 2.3 | 9.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 2.2 | 17.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 2.2 | 11.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 2.2 | 6.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 2.2 | 4.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 2.2 | 6.6 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 2.2 | 105.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 2.2 | 80.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 2.2 | 15.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 2.2 | 19.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 2.1 | 12.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 2.1 | 86.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 2.1 | 75.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 2.1 | 6.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 2.1 | 26.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 2.1 | 18.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 2.0 | 10.2 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 2.0 | 32.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 2.0 | 10.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 2.0 | 23.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 2.0 | 21.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 2.0 | 13.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 2.0 | 3.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 1.9 | 5.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.9 | 11.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 1.9 | 7.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 1.9 | 5.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.9 | 93.7 | GO:0070888 | E-box binding(GO:0070888) |
| 1.9 | 7.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 1.9 | 9.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.9 | 7.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.9 | 5.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.8 | 9.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 1.8 | 79.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 1.8 | 7.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 1.8 | 14.3 | GO:0016831 | carbon-carbon lyase activity(GO:0016830) carboxy-lyase activity(GO:0016831) |
| 1.8 | 12.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 1.8 | 24.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 1.7 | 13.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.7 | 22.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.7 | 17.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 1.7 | 598.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 1.7 | 12.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 1.7 | 20.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 1.7 | 30.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 1.7 | 35.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 1.7 | 8.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 1.7 | 93.4 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
| 1.6 | 8.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 1.6 | 32.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.6 | 16.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.6 | 11.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 1.6 | 1.6 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 1.6 | 6.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 1.6 | 3.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.6 | 9.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 1.5 | 4.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 1.5 | 6.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 1.5 | 16.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 1.5 | 4.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 1.5 | 4.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 1.5 | 5.8 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 1.5 | 7.3 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.4 | 4.3 | GO:0005254 | chloride channel activity(GO:0005254) |
| 1.4 | 2.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
| 1.4 | 31.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 1.4 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 1.3 | 33.0 | GO:0019956 | chemokine binding(GO:0019956) |
| 1.3 | 6.6 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 1.3 | 18.4 | GO:0005112 | Notch binding(GO:0005112) |
| 1.3 | 35.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 1.3 | 5.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 1.3 | 2.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.2 | 4.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 1.2 | 33.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 1.2 | 12.1 | GO:0043022 | ribosome binding(GO:0043022) |
| 1.2 | 6.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.2 | 9.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 1.2 | 2.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 1.2 | 13.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 1.2 | 5.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 1.1 | 18.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 1.1 | 3.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 1.1 | 8.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 1.1 | 12.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 1.1 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 1.1 | 2.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 1.0 | 7.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 1.0 | 4.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 1.0 | 7.0 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.0 | 3.0 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 1.0 | 2.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.9 | 4.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.9 | 19.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.9 | 9.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.9 | 11.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.9 | 17.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.9 | 3.6 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.9 | 1.8 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.8 | 1.7 | GO:0016597 | amino acid binding(GO:0016597) |
| 0.8 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.8 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.8 | 4.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.8 | 3.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.8 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.8 | 10.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.8 | 5.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.8 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.7 | 3.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.7 | 4.3 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.7 | 4.8 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.6 | 3.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.6 | 1.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.6 | 1.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
| 0.6 | 3.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.6 | 19.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.6 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.6 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.6 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.6 | 2.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.6 | 1.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.5 | 12.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.5 | 5.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.5 | 5.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.5 | 61.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.5 | 2.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.5 | 1.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.4 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.4 | 15.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.4 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 0.4 | 1.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 6.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 1.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.3 | 3.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.3 | 1.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.3 | 1.2 | GO:0016301 | kinase activity(GO:0016301) |
| 0.3 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.3 | 0.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.3 | 2.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.3 | 1.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 8.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.2 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
| 0.2 | 1.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 7.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 0.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.5 | GO:0032934 | sterol binding(GO:0032934) |
| 0.1 | 0.3 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.1 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 17.0 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.1 | 1.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.0 | 0.0 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 20.9 | 41.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 20.0 | 280.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 16.4 | 852.7 | PID BARD1 PATHWAY | BARD1 signaling events |
| 15.0 | 2034.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 13.7 | 453.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 13.6 | 108.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 12.4 | 955.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 10.7 | 321.5 | PID ATR PATHWAY | ATR signaling pathway |
| 10.4 | 114.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 10.2 | 427.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 10.0 | 500.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 9.8 | 565.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 9.3 | 895.4 | PID E2F PATHWAY | E2F transcription factor network |
| 9.2 | 425.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 9.0 | 208.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 8.8 | 437.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 8.7 | 8.7 | PID IFNG PATHWAY | IFN-gamma pathway |
| 8.4 | 225.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 7.8 | 15.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 7.7 | 724.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 7.6 | 122.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 7.5 | 218.1 | PID ATM PATHWAY | ATM pathway |
| 7.5 | 22.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 7.1 | 163.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 6.7 | 315.3 | PID FOXO PATHWAY | FoxO family signaling |
| 6.1 | 79.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 6.1 | 157.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 6.0 | 66.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 5.9 | 112.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 5.7 | 215.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 5.7 | 17.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 5.5 | 458.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 5.4 | 184.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 5.4 | 321.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 5.1 | 199.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 5.1 | 50.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 5.0 | 55.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 4.9 | 246.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 4.6 | 125.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 4.6 | 69.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 4.5 | 9.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 4.4 | 35.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 4.3 | 87.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 4.3 | 47.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 4.2 | 287.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 4.2 | 66.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 4.0 | 631.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 4.0 | 87.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 3.7 | 63.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 3.6 | 14.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 3.6 | 119.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 3.6 | 85.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 3.6 | 114.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 3.5 | 7.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 3.5 | 121.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 3.4 | 99.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 3.4 | 16.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 3.3 | 30.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 3.3 | 100.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 3.2 | 16.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 3.2 | 6.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 3.1 | 31.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 3.1 | 86.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 3.0 | 166.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 2.9 | 151.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 2.9 | 116.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 2.9 | 124.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 2.8 | 191.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 2.7 | 32.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 2.6 | 73.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 2.4 | 40.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 2.3 | 65.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 2.2 | 96.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 2.1 | 83.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 2.1 | 82.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 2.1 | 18.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 2.1 | 70.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 2.0 | 137.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 2.0 | 30.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 2.0 | 3.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 1.9 | 19.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 1.9 | 52.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 1.8 | 25.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 1.7 | 80.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 1.7 | 23.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 1.6 | 17.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.5 | 17.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 1.4 | 5.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 1.4 | 15.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 1.2 | 45.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.1 | 28.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 1.1 | 12.3 | PID INSULIN PATHWAY | Insulin Pathway |
| 1.1 | 12.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 1.1 | 5.4 | PID IGF1 PATHWAY | IGF1 pathway |
| 1.0 | 18.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 1.0 | 24.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.9 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 10.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.6 | 11.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.5 | 16.1 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.5 | 19.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.5 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.4 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 12.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.3 | 6.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 4.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 8.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 4.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 2.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 0.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 30.2 | 393.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 30.2 | 483.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 29.6 | 1007.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 28.0 | 111.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 27.3 | 2125.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 27.2 | 625.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 26.9 | 456.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 24.9 | 398.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 24.9 | 597.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 23.4 | 328.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 23.0 | 229.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 22.8 | 45.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 22.7 | 22.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 21.5 | 193.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 21.4 | 619.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 21.3 | 170.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 19.4 | 38.9 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 19.0 | 228.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 18.6 | 724.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 18.4 | 367.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 17.2 | 171.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 17.1 | 801.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 16.2 | 16.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 16.0 | 560.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 15.7 | 438.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 15.5 | 310.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 15.5 | 402.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 15.4 | 584.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 15.3 | 951.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 15.3 | 198.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 15.2 | 242.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 15.0 | 269.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 14.8 | 89.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 14.5 | 3620.9 | REACTOME TRANSLATION | Genes involved in Translation |
| 14.2 | 185.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 14.2 | 70.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 13.8 | 220.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 13.8 | 288.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 13.7 | 13.7 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 13.4 | 253.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 12.9 | 102.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 12.9 | 462.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 12.3 | 357.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 12.2 | 170.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 11.8 | 1442.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 11.8 | 364.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 11.7 | 94.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 11.7 | 163.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 11.7 | 70.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 11.6 | 277.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 11.4 | 68.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 11.1 | 298.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 10.9 | 196.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 10.6 | 201.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 10.5 | 178.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 10.3 | 10.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 10.1 | 100.6 | REACTOME S PHASE | Genes involved in S Phase |
| 10.0 | 230.4 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 9.8 | 852.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 9.8 | 175.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 9.8 | 107.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 9.7 | 203.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 9.4 | 253.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 9.2 | 357.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 9.1 | 9.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
| 9.1 | 27.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 8.9 | 107.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 8.6 | 94.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 8.4 | 76.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 8.4 | 673.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 8.3 | 1299.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 8.2 | 155.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 8.1 | 64.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 7.9 | 245.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 7.7 | 30.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 7.6 | 15.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 7.5 | 241.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 7.3 | 139.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 7.2 | 354.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 7.2 | 115.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 7.2 | 72.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 7.2 | 129.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 7.2 | 515.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 7.1 | 191.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 7.1 | 389.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 7.1 | 134.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 7.0 | 70.2 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 7.0 | 168.0 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
| 7.0 | 111.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 6.9 | 97.0 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 6.8 | 156.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 6.5 | 38.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 6.5 | 361.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 6.2 | 6.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 6.1 | 61.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 6.0 | 149.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 5.9 | 41.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 5.9 | 204.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 5.7 | 114.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 5.7 | 57.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 5.6 | 38.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 5.4 | 70.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 5.4 | 48.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 5.3 | 232.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 5.2 | 160.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 5.1 | 10.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 5.0 | 74.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 4.8 | 82.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 4.8 | 119.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 4.8 | 9.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 4.8 | 61.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 4.8 | 85.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 4.7 | 172.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 4.6 | 55.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 4.6 | 4.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 4.6 | 300.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 4.6 | 50.4 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 4.6 | 68.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 4.3 | 146.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 4.2 | 29.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 4.1 | 78.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 4.1 | 359.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 4.0 | 185.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 4.0 | 390.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 3.9 | 35.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 3.9 | 31.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 3.7 | 82.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 3.7 | 56.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 3.7 | 33.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 3.7 | 37.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 3.3 | 132.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 3.2 | 67.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 3.2 | 143.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 3.2 | 54.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 3.2 | 54.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 3.2 | 130.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 3.1 | 75.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 3.1 | 92.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 3.0 | 9.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 2.9 | 123.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 2.9 | 76.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 2.9 | 55.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 2.9 | 2.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 2.9 | 312.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 2.9 | 34.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 2.8 | 36.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 2.8 | 67.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 2.8 | 61.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 2.8 | 13.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 2.7 | 24.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 2.7 | 10.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 2.6 | 5.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 2.5 | 42.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 2.3 | 11.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 2.2 | 31.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 2.2 | 19.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 2.1 | 80.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 2.1 | 16.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 2.0 | 26.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 2.0 | 33.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 2.0 | 53.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 1.9 | 27.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 1.9 | 22.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 1.9 | 39.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 1.8 | 19.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.5 | 32.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 1.5 | 209.5 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 1.4 | 85.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 1.3 | 26.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 1.3 | 29.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 1.3 | 17.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 1.2 | 16.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 1.1 | 15.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 1.0 | 33.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 1.0 | 25.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 1.0 | 23.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 1.0 | 103.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.9 | 22.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.9 | 9.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.8 | 9.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.8 | 30.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.7 | 2.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.7 | 5.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.6 | 4.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 9.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.5 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.5 | 8.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.5 | 9.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.5 | 44.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.4 | 2.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.4 | 6.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.4 | 5.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 7.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.3 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.3 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 13.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.2 | 6.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 2.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 0.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.1 | 8.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 2.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 5.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |